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INTRODUCTION 
 
 
Epidural anaesthesia requires larger amounts of local anaesthetic 
than a spinal anaesthetic. Close attention to the total dose is required to 
avoid toxicity. Epidural anaesthesia is versatile and can be administered by 
a single injection or through a catheter. The use of a catheter allows the 
anaesthesia provider to add local anaesthetics as surgery progresses, 
extending duration beyond the original dose. 
 Epidural anaesthesia provides excellent operating conditions for 
surgical procedures below the umbilicus like inguinal hernia 
repair,incisional hernia repair,genitourinary procedure and lower 
extremities surgeries  
In lower abdominal surgeries various anaesthetic techniques have 
improved drastically over last few decades.Manytechniques anddrug 
regimenswith great  success have been tried from time to time to calm the 
patient and to eliminate the anxiety. 
Theprolonged duration of surgeries,sensory and motor block, supine 
position for a long time and the immobility brings a feeling of discomfort 
and anxiety  to the patients during regional anaesthesia.  
Sedatives are given to alleviate the anxiety,but higher doses may 
produce respiratory depression in some patients. To overcome this 
disadvantage newer drugslike alpha2Aselective agonist has beentried 
 
 
toinduce the natural arousable sleep without causing respiratory 
depression.It has been mixed with local anaesthetic agent as adjuvant. 
Dexmedetomidine is a highly selective alpha2 agonist with a greater 
affinity towards adrenergic receptor than clonidine.The analgesic property 
and the local anaesthetic property are  due to the hyperpolarisation of nerve 
tissues by altering transmembrane potential and ion conductance at locus 
ceruleus in the brain stem.The stable hemodynamics and the decreased 
oxygen demand due to enhanced sympathoadrenal stability, make it 
apreferable adjuvants with local anaesthetics.It provides better sedation 
throughout the procedure without causing respiratory depression. The 
administration of dexmedetomidine through various routes created the 
interest of this study to compare the routes of administration of the drug to 
assess the efficacy of   basic qualities of the drug like analgesia,sedation, 
cardiovascular and respiratory responses. 
 
 
 
 
 
 
 
AIM OF THE STUDY 
To assess the efficacy of epidural dexmedetomidine and Intravenous 
dexmedetomidine in patients undergoing lower abdominal surgeries under 
epidural anaesthesia.  
Efficacy is assessed in terms of  
I. Sensory block. 
II. Motor block. 
III. Time for two segment level regression.  
IV. Time for rescue analgesia.  
V. Intra operative sedation score. 
VI. Hemodynamic stability. 
 
 
 
 
 
 
 
 
 
HISTORY 
WILLIAM STEART HALSTESD (1852-1922) and RICHARD 
JOHN HALL (1856-1897) were the true progenitors of conduction 
anaesthesia. In 1855, FRIEDRICH (1828-1890) became the first person 
to isolate cocaine, In 1884,KARL KOLLER (1857-1944)studied the local 
anaesthetic effect of cocaine by instilling cocaine into his own eye. 
JAMES LEONARD CORNING (1855-1923)was the first to use 
epidural analgesia in1885. Caudalepidural analgesia has been practised as 
technique since 1901 by SICARD and CATHELIN(Paris,France). It was 
introduced as caudal approach.Lumbar approach for epidural analgesia 
was tried by TUFFIER in 1901.Continous epidural anaesthesia through 
caudal route was initially described by EUGEN BOGDAN 
ABREUL(1899-1975). 
Twenty years later, in 1921, FIDEL PAGES (Spain,1886-1923) 
describedthe injection of anaesthetics into the epidural space in the lumbar 
and thoracic regions, and this markedly increased the possibilities of the 
epidural block.FIDEL PAGEScreated interest in midline easy approach 
for lumbar epidural. 
 
 
 
ACHILE MARIO DOGLIOTTI (Italy,1897-1966) was a 
surgeon.He advocated the use of epidural anaesthesia for a wide variety of 
procedures since 1931. 
DOGLIOTTIfirst described the loss of resistance technique and 
classic grip of needle and syringe . 
VINCENT RUIZ AND ALBERTO GUTIERREZ (Buenos 
Aires,Argentina )began their practice of epidural anaesthesia based on the 
work of both PAGES AND DOGLIOTTIin 1932.GUTIERREZ 
developed the „HANGING DROP‟ sign used to identify the epidural 
space. In 1941, ROBERT ANDREW HINGSON and WALDO 
B.EDWARD developed continuous caudal anaesthesia using indwelling 
needle. 
 In 1947, MANUEL MARTINEZ CURBELOfirst described the 
placement of a lumbar epidural catheter. JANES (1926) noted Epidural 
needles with lateral opening are better suited to avoid dural puncture by 
epidural pressures exerted during procedure than conventional blunt 
bevelled needle. 
Tuohy needle initially designed for continuous subarachnoid 
analgesia by TUOHY(1945).It was adopted for epidural use by 
CURBELO.  
 
 
Tuohy needle are produced with a blunted upper rim to avoid shear 
of the catheter introduced by LUND (1966).Later developed epidural 
needle, catheter and better understanding the concepts of newer drugs 
pharmacokinetics and pharmacodynamics contributed to the safer epidural 
anaesthesia.Nowadays, epidural analgesia is an essential technique in 
anaesthesiology. 
The first report on opioids for intra thecal anaesthesia was published 
in 1905 and on epidural morphine in 1979. Various  non opioid  adjuvant 
usedin neuraxial analgesia to improve the efficacy included NMDA 
antagonists -ketamine , magnesium, GABA agonists-Midazolam, COX 
inhibitors-ketorolac,Acetyl choline esterase-Neostgmine,Adrenergic 
agonists-Adrenaline, clonidine. 
Alpha 2-adrenoceptor agonists are being increasingly used in 
anaesthesia and critical care, as they not only decrease sympathetic tone 
and attenuate the stress responses to anaesthesia and surgery but  also 
produce sedation and analgesia.They are also used as an adjuvant during 
regional anaesthesia.Dexmedetomidine is the agent in this group approved 
by FDA in 1999 for use in humans for analgesia and 
sedation.Dexmedetomidineproduces apowerful antinociceptive effect, 
mediated at spinal level and systemic redistribution of the drugs lead to 
hypnotic state. 
 
 
ANATOMY 
    Identification of spinous process corresponds to certain landmarks 
which are essential to identify the appropriate levels to block 
corresponding dermatomes. 
C7-Prominent cervical spine. 
T3-Tip of spinous process scapula. 
T5-Lowest point in thoracic curve on lying supine. 
T7-Tip of inferior angle of scapula. 
L3-Highest point in lumbar curve on lying supine. 
L4-Highest point of iliac crest. 
S2-Posterior superior iliac spine. 
Vertebral column: 
Cervical and lumbar curvatures are convex anteriorly, thoracic and 
sacral curvatures are convex posteriorly. In supine position the highest  
point of the cervical curvatures  is  at C5 and the lumbar curvature is  at 
L5.The lowest point of the thoracic curvature isat T5, the sacral curvature 
is  at S2.These curvatures have the influence in spreading of local 
anaesthetic in the subarchnoid space.     
 
 
    The typical lumbar vertebra has kidney shaped body and a triangular 
vertebral foramen .The spine is straight when viewed from back and square 
shaped when viewed from sideways.There are noarticular facet for ribs as 
in thoracic vertebra. The stability and  elasticityof vertebral column is 
provided by various ligaments. Supra spinous ligament connects as a 
fibrous cord from C7 spinous process to sacrum. Interspinous ligament is 
present between the ligamentumflavum anteriorly and the supraspinous 
ligament posteriorly. Both of the ligaments are thickest and broadest atthe 
lumbar region.  
Ligamentumflavum is a yellow elastic ligament connecting the caudal 
edge of upper vertebral laminae and cephalad edge of lower vertebral 
laminae.  
Anterior andposterior longitudinal ligaments binds with the vertebral 
bodies. Intervertebral foramina which transmits the spinal nerves is 
bounded anteriorly by intervertebral disc, posteriorly by the articulating 
process, superiorly and inferiorly by the pedicles of adjoining vertebra.   
SPINAL CORD AND NERVE ROOTS: 
The spinal cord is 42-45 cm in length and occupies the two third of 
the vertebral canal. 
 
 
It is a continuation of medulla oblongata and ends as conusmedullaris.   
The filumterminale stretches downward and attaches to the coccyx. 
At birth the spinal cord ends at the lower level of L3. In adult the 
spinal cord ends atthe  level of lower border of L1 or the  upper border of 
L2.In cross section there is an anterior median fissure and a posterior 
median septum. The anterior median fissure extends 3mm into the cord 
and contain blood vessels and also where the local anaesthetic solution 
enters the cord.  The posterior sulcuscontain neuroglia. 
There are 31 pairs of spinal nerves.The anterior and posterior root 
cross the subarachnoid space,dura, extradural  space and unite in the 
intervertebral foramen and forms the spinal nerve trunk.Thetrunk is  
divided into anterior and posterior primary division.The autonomic fibers 
are more sensitive whereas the motor fibers are least sensitive.  The 
sympathetic preganglionic axonsarise from intermediate lateral horn at the 
firstthoracic level and extendsupto the second lumbar vertebra.The nerve 
roots are larger in cervical and in lumbo sacral region than in thoracic 
region. Extension of sympathetic block higher level than motor block.   
 
 
 
 
 
Blood supply:  
The spinal cord is supplied by one anterior spinal arterywhich is a 
branch of the vertebral artery formed at the foramen magnum.It lies on the 
median fissure.It descends downwards from the foramen magnum to the 
filumterminale.  
The spinal cord is also supplied by a pair of posterior spinal artery 
which is a branch of posterior inferior cerebellar arteries.Lowerbranches 
provides blood supply to caudaequina.These posterior vessels also supply 
the nerve roots which emerges through the intervertebral foramina. 
Anastomosis between anterior and posterior spinal arteries is not found. 
Anterior radicular and posterior radicular arteriesvariable in size  and  
number  which  the posterior spinal arteries.One of the anteriorradicular 
arteries with branches from intercostal arteries and larger in size forms 
arteriaraicularis magna or artery of Adamkiecz .It provides blood supply 
tothe lower third of  spinal cord. 
ANATOMY OF EPIDURAL SPACE : 
The epidural space extends from the foramen magnum to the sacral 
hiatus This space is limited superiorly, by the fusion of the spinal and 
periosteal layers of the duramaterat the foramen magnum.Inferiorly, it 
extend upto the sacrococcygeal membrane. 
 
 
The other boundries of the epidural space include  
i. Anteriorly,theposterior longitudinal ligament,vertebral bodies and 
intervertebral discs.  
ii. Posteriorly, the ligamentumflavum,facet joints and laminae. 
iii. Laterally, the pedicles and intervertebral foramina. 
The epidural space varies with vertebral level ranging from 1.5mm at 
C5,2.5 mm at T6, 5 to 6 mm at L2 level is the widest epidural space . 
Thecontents of the epidural space include nerve roots, fat, areolar 
tissues,lymphatics,and venous plexus. Epidural space is notvoluminous 
assub arachnoid space.  
The anterior Epidural space is narrow because proximity of dura and 
anterior surface of vertebral canal. The posterior epidural space is widest 
occupied by nerves, fat and fibrous tissue.  
The  local anesthetic spread occur superiorly to the base of skull, 
inferiorlyto the caudal canal with seepage into anterior sacral foramina and 
leaks through interveretebral foramina into paravertebral space. Local 
anaestheticsspreads horizontally  through the region of dural cuff with 
entry into CSFand minor into anterior epidural space.  
The rapid entry of local anaesthetic occurs into CSF via arachnoid 
granulations. The dural space is narrow at the posterolateral aspect of the 
vertebral canal.  
 
 
The spread of local anaesthetics injected into epidural  space is not 
predictable due to the fatty areolar tissue that offers resistance as well as 
the foramina through which the fluid leaks but still this block can be made 
reliable to provide analgesia. 
The space is triangular with the apex in the dorso-medial 
aspect.Sometimes the dura mater divides the space into two dorsolateral 
compartments and a ventral compartment. The veins in the space are 
distended during pregnancy. 
 
 
 
 
 
 
 
 
 
 
      
 
 
 
 
PHYSIOLOGICAL CONSIDERATIONS 
 
The epidural anaesthesia  results in blockade of autonomic nerves , 
sensory as well as motor fibres . 
Autonomic nervous system: 
 The preganglionic sympathetic axons are present in the intermedio-
lateral horn of spinal cord from first thoracic vertebra to second lumbar 
vertebra.  
They are myelinated and travel along the anterior roots and pass in 
to the white rami to the paravertebral ganglia.Large concentration of local 
anaesthetics is required to provide the expected sensory and motor 
blockade.The motor fibers are less blocked than sensory fibers since motor 
fibers are covered by duralsheath.The  large  dose itself cause 
physiological changes due to increased plasma concentration.Complete 
sympathetic block lead to unopposed parasympathetic activity and causes 
bradycardia andhypotension.In epidural anaesthesia hypotension can be 
controlled by providing titrated dose according to level requirement. Spinal 
roots and trunk is blocked at axonal level. Peripheral sympathetic block 
can be achieved by blocking efferent stimulus from T10 to L2 level .  
 
 
Adrenal medullary sympathetic blockade is achieved by blocking T6 
to T11 segments which lead to splanchnic vasodilation and decreased 
circulating catecholamines. 
T1 to T4 segmental block causes cardiac accelerator fibers inhibition 
and leads to increased parasympathetic activity with bradycardiaupper 
limb vasodilatation and lower limb compensatory lower limb 
vasoconstriction. 
The particulate size of 0.4-1.5µg cross the dural sheath.Occasionally 
spread of the drug occurs to the spinal cord itself through the arachnoid 
villi.Lipid solubility enhances the spread of local anaesthetic whereas the 
regional blood flow in the nervous tissue is responsible for the rate of 
removal of local anaesthetic.  
Effects on respiratory system: 
Sensory afferent pathway blockade reduces nociceptive impulses to 
respiratory centre and the efferent pathway blockade causes intercostal and 
abdominal muscle paralysis, it may impair the ability to cough 
effectively.Epidural  analgesia  in  post operativeperiod provide good pain 
relief thereby improve the functional residual capacity.Total spinal 
anaesthesia following inadvertent intradural injection of an epidural local 
anaesthetics cause  higher respiratory centre depression and apnoea as a 
 
 
consequence of decreased blood supply to medullary centre due to 
decreased cardiac output.  
Indeed spontaneous respiration is a valuable monitor of the 
adequacy of cerebral blood flow during hypotension. Emphysematous 
patient breath easily probably due to reflex bronchodialation which results 
from the effect of hypotension on baroreceptor.   
Effects on cardiovascular system:  
Higher blockadeis  likely to be associated fall in arterial pressure, 
stroke volume, cardiac output and peripheral resistance.Peripheral 
venodialation causes pooling of blood and leads to decrease preload to the 
heart and cause reflex bradycardia.In supine position in pregnancy, inferior 
vena cava compressed by uterus, causes peripheral venous pooling and 
engorgement of epidural vessels lead to decreased blood supply to spinal 
cord. It is promptly treated with lateral positioning,intravenous fluid, 
vasopressors to maintain mean arterial pressure within normal limit. 
Adrenaline absorption from epidural space results in stimulation of 
the  beta receptors and increases the cardiac output but the peripheral 
resistance decreases and there is a fall in  mean arterial 
pressure.Sympathetic blockade of the lumbar extradural block enhances 
fibrinolysis above T8 so it is a possible contraindication for prostatectomy.    
 
 
Liver: 
 Epidural block up to T5 level with lignocaine alone decreases the 
hepatic blood flow and decrease the splanchnicvascular resistance.  
Effects on Gastrointestinal system:  
Epidural block extending from T6 lead to splanchnic sympathetic 
denervation and results in small contracted gut.Gastric emptying is delayed 
with epidural morphine but not with epidural local anaesthetics. Epidural 
local anaesthetics may decrease the incidence of post 
operativeileus.Intestinal anastomosis performed under epidural analgesia 
shows lower  anastamotic leak incidence.  
Thermoregulation and shivering: 
Sympathectomy induced vasodialation produce central hypothermia 
through the convection of heat from central part of body to peripheral 
tissues. 
Incidence of decreasing core body temperature due to loss of heat to 
environment due to vasodialation below the level of blockade and 
vasoconstriction and shivering above the level of blockade. Incidence of 
shivering following epidural block is noticed in one third of the patients. 
 
 
 
Epidural anaesthesia may decrease the endocrine and metabolic 
alteration during surgery by blocking afferent and efferent pathway. The 
extent of block and surgery site influence the block of nociceptive 
impulses. 
Factors that affect the height of epidural anaesthesia are the following:  
Age,Height and Weight of the patient. 
Volume ,dose and concentration of the drug.  
Position,Gravity, Injection site, Pregnancy and Speed of the injection. 
Age  
With increase in the age,the local anesthetic  requirement is reduced 
to achieve the same level of blockade as their younger counterpart. The 
effect of age on epidural blocks have demonstrated a greater spread in 
older patients.This is thought to be related to a less compliant epidural 
space and dura mater.but, the clinical effect is usually at most an increase 
of no more than three to  four dermatomes. 
Height and Weight: 
The correlation between patient height or weight and spread of 
epidural block is very weak at best and seems to have no clinical 
significance. 
 
 
The only instance where it may have an effect is in extremely tall 
people or in extremely short or in morbidly obese patients. 
Gravity  
Positioning the patient after injection of local anaesthetic into the 
epidural space impacts its spread and height, but not to the degree that it 
does with spinal anaesthesia. A Trendelenburgposition may help in spread 
of local anesthetics and the reverse Trendlenberg limit its spread. 
Volume: 
Dosing an epidural can be variable. An epidural should be placed at 
an appropriate level that corresponds to the dermatome level of the 
intended surgical procedure since epidurals produce a segmental block.  
A small volume of a more concentrated local anaesthetic will 
produce a very limited but very strong block. The increase in block level is 
not proportion to the volume increase. Doubling the volume will not 
double the block spread. It is non linear relationship and doubling the 
volume will only increase the level about one third to half of  the original 
segment. Cervical and thoracic doses are 0.7 to 1 ml per segment with an 
initial volume of 10ml. Lumbar level dosesare 1.25 to 1.5 ml per segment.           
This variation is due to narrowing of the spinal canal as it progress 
cranially.Since the dose may be variable from patient to patient, it is 
 
 
important to give the epiduraldose  in increments while continually 
assessing block progression. A segmental block for epidural analgesia 
would require a smaller dose.The dose of local anaesthetics administered 
in the thoracic region should be decreased by 30-50% due to a decrease in 
compliance and volume. 
Concentration: 
Concentrationof the drug is relatively unimportant in determining 
block spread.If drug concentration is held constant, increasing the volume 
of local anaestheticsresults in significantly greater average spread. 
The concentration of the local anaesthetic generally affects the 
density of the block, not the spread.Dose & volume, however, are 
important variables in determining both spread and quality of the epidural 
block obtained. 
Position: 
 The lateral position is the preferred position to optimize spread. But 
in someindividuals sitting position is preferred due to anatomical 
advantages. There isno differences in spread ofblock when comparing  
the two positions. 
 
 
 
 
 
Injection site: 
Unlike spinal anesthesia, epidural anesthesia produces a segmental 
block that spreads both caudally and cranially.Theinjection site in 
determining the spread of an epidural block is controversial .The injection 
site should be in the middle of the range of dermatomes that needs to be 
anesthetized and closest to the main nerve roots involved.Lumbar local 
anesthetic injections of 10ml tend to spread caudad to include all the sacral 
dermatomesLumbar injections of 20ml volumes produce much better 
quality sacral blocks and can also extend cranially to include the 
midthoracic levels. 
Pregnancy: 
Greater spread occurs at term and early in pregnancy.There is no 
significantdifferences in level of spread between pregnant and non-
pregnant patients. 
Speed of injection: 
The rapid injection will increase the level of spread or decrease the 
time it takes for the block to set.This has never been shown to make any 
difference in eitherdrugs should be injected slowly to avoid rapid increases 
in CSF pressure, headache and increased intracranial pressures.Also, 
incremental bolus compared with slow, steady injection has shown no 
 
 
difference in level of spread. Local anaesthetic solutions are injecting 
through the catheter. 
This gradual administration of medication slows the rate of onset of 
the anesthetic level and controls the development of the sympathetic 
blockade.This is an advantage with an epidural anaesthesia than 
spinalanaesthesia.The Spinalanaesthesia is All or None phenomenon, 
whereas the epidural can be brought up gradually, slowing the hypotensive 
response. 
Possible site of local anaesthetic action: 
I. Paravertebral nerve roots. 
II. Intradural spinal roots. 
III. Dorsal and Ventral spinal roots. 
IV. Dorsal root ganglia. 
V. The Spinal Cord. 
VI. The Brain by diffusion. 
Initial blockade is probably a result of anesthetic blockade at the spinal 
roots within the dural sleeves. 
The duralsleeves have a proliferation of arachnoid villi and 
granulations that effectively reduce the thickness of the dura mater 
facilitating rapid diffusion of the local anaesthetic from the epidural space, 
through the dura and into the CSF surrounding the nerve roots. 
 
 
Then the local anesthetic diffuses into the nerve root itself, 
producing anesthesia to that particular dermatome. Because epidural 
anaesthesia is diffusion dependent, relatively large volumes of local 
anaesthetic are needed to achieve a block that spans several dermatome. 
The block goes as high or low as the volume injected. It is not like 
spinal anaesthesia where the complete block occur distal to the site of 
injection. It is a differential block dependent on the volume and site of 
injection. 
Spread of local anaesthetic drugs within the epidural space: 
 
Local anesthetics when administered in to the epidural space moves 
in a horizontal and longitudinal direction.  
Theoretically, local anesthetic when injected, it can spread up to 
foramen magnum cranially and to the sacral foramina caudally. 
Clinically, the extent of longitudinal spread is dependent on the 
volume of the drug injected,hence the cephaladspread  of the drug can be 
limited.In the epidural space the spread of the local anaesthetic solution 
spreads in only four additional dermatomes. Horizontal spread of the local 
anaesthetic solution occurs through intervertebral foramina, entering the 
dural cuff. A small amount of local anesthetic sometimes enters the 
anterior epidural space. 
 
 
Diffusion into the CSF occurs through arachnoid granules in to the 
dural cuff. 
Onset of blockade: 
The onset of an epidural block can usually be detected within 5 
minutes in the dermatomes immediately surrounding the injection site.The 
time to peak effect differs somewhat among different local 
anesthetics.Shorter acting drugs usually reach their maximum spread in 15-
20 minutes. 
Longer acting local anesthetics usually reach their maximum spread 
in 20-25 minutes.Increasing the dose of local anesthetics speeds the onset 
of both motor and sensory block 
Duration of block: 
The duration of the Epidural block depends on the local anesthetics 
itself, dose,Patient age,use of adrenergic agonists and adjuvants. 
Local anaesthetics and duration: 
Chloroprocaine is shortest acting,Lidocaine&Mepivacaine are 
intermediate acting local anaesthetics.  
 Bupivacaine and ropivacaine produce the longest lasting epidural 
blocks.Bupivacaineis a long acting agent on sensory block than muscle 
relaxation. 
                                           
 
 
In lower concentrations bupivacaine seems to have a preferential 
sensory block with minimal motor effect. 
Adrenergic agents and duration: 
Adrenaline in a concentration of 5 micrograms per ml (1:2,00,000) 
is added to the epidural local anaesthetic solution. 
The dose of lignocaine with adrenaline is 7mg/kg whereas without 
adrenaline it is 3mg/kg. It has been shown to prolong the blocks 
oflignocaine and mepivicaine by as much as 80%. Adding adrenaline with 
bupivacaine and ropivacaine does not significantly prolongs the duration 
of surgical anaesthesia. 
TECHNIQUE OF EPIDURAL BLOCKADE: 
Either the sitting or lateral decubitus positions can be used. 
Emergency equipment,drugs and monitors should be immediately 
available.The lumbar region is by far the easiest due tothe angle of the 
spinous processes. 
The largerspaces between adjacent spinous processes.Easily 
identifiable location by using easy to find iliac crests as land mark.Width 
of epidural space is greatest at this level. 
In epidural space, catheter tip is placed between ligamentumflavum 
and dura. 
 
 
 
Structures encountered in midline approach are skin,subcutaneous 
tissuethen to penetrate supraspinatous ligament,interspinous ligament, 
increased resistance offered by ligamentumflavum once the tip of the 
needle entered into the ligamentumflavum. 
Within a few millimeter,a sudden loss of resistance is felt and the 
needle enter into epidural space. The distance of epidural space from skin 
varies from 3 to 8 cm. Epidural catheter should be in high tensile strength 
with low coefficient of friction. It should have atraumatic tip, depth marker 
and radio opacity property. 
The epidural anaesthesia is performed with a blunted tip the Tuohy‟s 
needle designed to facilitate passage of a catheter into the epidural 
space.The blunted tip is also designed specially to avoid puncture of the 
dura and if it comes in contact with the dura, the blunt tip will hopefully 
just inwardly push the dura without puncturing it. 
Local anaesthetic ( Lignocaine 1% plain) is injected at T12-L1 
interspace and a skin wheal is raised with an injection of 2-3 mlof 
lignocaine with the 22 gauge intramuscular  needle, and in the center of the 
skin a wheal is raised and then deeper along the planned injection tract, 
injecting slowly as they penetrate deeper into the subcutaneous tissue. 
 
 
 
Firmly the back of the non-dominant hand against the patient‟s 
skin,then the epidural needle and eventually the hub is grasped  and once 
the epidural space is found the needle is held between the thumb and index 
finger of the non-dominant hand as it stays in contact with the patient‟s 
back .This stabilizes the needle and prevents any unwanted movement 
either in or out which is especially critical once the epidural space is found. 
The epidural needle is place bevel up and introduced into the skin.It 
is passed slowly through the supraspinous ligament and seated in the 
interspinous ligament before the stylet is removed. The needle is placed in 
the interspinous ligament the stylet is removed, the needle is slowly 
advanced using the “Loss of Resistance” technique. 
The LOR syringe is typically made of glass and is filled with either 
3-4cc of air, normal saline.As the syringe or needle combo is advanced, 
pressure is applied to the plunger of the syringe by “Bouncing” or 
intermittently applying pressure to the plunger.The pattern is move-bounce 
until loss of resistance is obtained.The needle combo should only be 
moved 0.5-1mm at a time and then tested for resistance or loss of 
resistance. 
The syringe and needle combo is advanced by applying pressure to 
the needle and not the syringe. 
 
 
As the needle passes through the ligamentumflavum, resistance 
increases and “pop” of is felt as the ligamentumflavum is pierced and once 
the tip of the needle is in the epidural Space. 
Once the epidural spaceis reached, pass thestylet through the needle 
to made sure there are no tissue plugs possibly blocking the flow of CSF 
with an inadvertent dural puncture.Once it is determined that theneedle 
tipis in theepidural space,  a test  dose of 3ml of 1.5% of  lignocaine with 
adrenaline.It is essential to question the patient after the injection of test 
dose. 
The aim of the question is to determine whether inadvertent dural 
puncture or the  possibility of  injecting directly into the vascular system.If 
the drug is in intravascular, an increase in heart rate within 30 seconds is 
noticed.With an intravascular injection,patient may experience “buzzing” 
sound in the ears, a metallic taste in the mouth or circumoral numbness.If 
the drug enters into subarachnoid space weakness of the great toe is 
noticed.  
A 16 G or 18 G catheter is threaded up to a point of 5cms added to 
the skin to reach the epidural space distance.Initially a resistance is felt at 
the tip of the needle.A slight push may be needed to advance the catheter 
smoothly. 
 
 
 
The catheter should not be pulled out of the the needle once it has 
been inserted, as the catheter may trap on the needle tip and shear or cut 
the tip off. 
Hanging drop method is an alternative technique to loss of resistance 
to   identify   epidural space. In this method a drop of saline is kept at the 
edge of the epidural needle hub is sucked into needle once tip reaches the 
epidural space.  
Advantages: 
Epidural techniques have the advantage of better control of level and 
sympathetic blockade. 
Continous epidural catheter is useful in  
I. Regional anaesthesia  including abdominal surgeries and lower limb 
surgeries 
II. Obstetric Analgesia. 
III. Prolonged postoperative analgesia 
IV. Cases of unpredictable duration and chronic pain control. 
Contraindications: 
Absolute contraindication: 
Patient refusal,Infection at puncture site,Raised intracranial tension, 
Coagulopathy. 
 
 
 
Relative contraindication: 
Pre-existing spinal cord disease, deformities of spinal cord, 
sepsis,chronic headache or backache,hypovolemia 
SIDE EFFECTS AND COMPLICATIONS: 
The complications are attributed to physiologic changes are 
hypotension,bradycardia,urinary retention,shivering. Thoseattributable to 
the procedure are dural puncture resulting in post dural puncture 
headache,inadvertent high level of block due tointrathecal injection of 
drugs due to migration of catheter into sub arachnoid space.  
Vascular puncture may lead to the development of epidural hematoma 
which leads to cord compression and its sequence. 
Patient may also develop local anaesthetic toxicity due to accidental 
intravascular injection due to catheter migration.Large dose of local 
anaesthetics required for epidural anaesthesia and the presence of 
numerous venous plexus in the epidural space increase the likelihood of 
substantial systemic absorption. 
Patient may presented with mild CNS symptoms like restless,slurred 
speech,tinnitus to loss of conscious, seizure and cardiovascular collapse. 
Nerve injury is very rare,but occur after paraesthesia developed 
during performance of the technique. Other complications include epidural 
 
 
abscess, meningitis, accidental subdural injection produce unusual 
block.Characterized by patchy sensory block and unilateral dominance. 
Sub dural placement catheter is dangerous because catheter can 
abruptly pierce the thin arachnoid membrane and enter into subduralspace. 
Differentiation between high epidural and total spinal anaesthesia : 
Epidural space ends at foramen magnum cranialy, so the cranial nerves  
are not blocked by epidural anaesthesia. Even with high sensory blocks 
there are areas of sensation not affected by epidural anaesthesia because 
they are innervated byafferent fibres  in the cranial nerves . 
The occulomotor nerve induces miosis after opioid administration so 
preservation of this response differentiates high epidural anaesthesia from 
total spinal anaesthesia. 
Signs of successful lumbar epidural block: 
I. Feel of heaviness or numbness in the lower limb. 
II. Sluggishness or absence if knee jerk or ankle jerk. 
III. Relaxation of anal sphincter tone by rectal examination suggests 
sacral block. 
IV. Fall in blood pressure 
V. Warm lower extremities due to vasodilatation caused by  
sympatheticblock. 
 
 
VI. Scaphoid abdomen due relaxation of abdominal muscles and 
reduced intra abdominal pressure. 
VII. No effective cough reflex or the abdominal wall do not stiffen on 
coughing with high segmental block.  
 
LIGNOCAINE: 
In 1905, Einhorn introduced the ester local anaesthetic procaine. 
In 1943, Lofgren introduced lignocaine in sweden it is a protypical amide 
local anaesthetic. Gordhused lignocaine in 1948. Ester local anaesthetics 
is instability in solution short action, degradation when exposed to high 
temperature, increased incidence of allergic reaction . 
 
 
 
 
 
 
 
      
 
 
 
 
PHARMACOLOGY OF LIGNOCAINE 
Physiochemical properties of Lignocaine: 
Lignocaine is a synthetic amide-local anaesthetic of intermediate 
potency and duration. It is 2-Diethylaminoaceto-2‟6‟-xylitide It is 
stable,clourless,crystalline solid.Lignocaine HCL readily souble in water.It 
is less lipid soluble than bupivacaine. It is a weak base. It is not 
decomposed by boiling,acids or alkalies. 
pKa - 7.6-7.8. 
Molecular weight -234.34 g/mol. 
Mechanism of action : 
Local anaesthetics prevent conduction blockade by inhibiting 
passage of sodium channels in nerve membranes. Blocking the open 
sodium channels by lignocaine molecule contributes partial to complete 
inhibition of sodium permeability thereby slowdown the rate of 
depolarisation so that threshold potential could not be achieved.Thus the 
action potential is not propagated.  
Sodium channel exist in activated open state, inactivated closed 
state, rested closed during various phase of the action potential. 
 
 
 
Lignocaine selectively inhibit the sodium channels in inactivated 
state, local anaesthetic molecules stabilise these sodium channels and thus 
prevent their change to rested closed and activated open states in response 
to nerve impulses. 
Other site of action includes voltage dependent potassium ion 
channels. Voltage sensitivity calcium ion channel (L-type )may also be 
blocked . 
 
DISTRIBUTION, UPTAKE AND ELIMINATION: 
 
Around 6-8 times the amount of local anaesthetic is required in 
epidural anaesthesia to produce the same degree of blockade as produced 
in subarachnoid block. 
This is due to the following factors:  
Local anaesthetics are lipid soluble and are absorbed into epidural 
fat. Local anestheticsmust penetrate the dura mater to block the larger 
mixed nerve roots are found in the epidural space. 
Epidural vessels absorbs a significant amount of local anaethetic 
solution injected . The peak blood concentration occur 10-30 min after a 
bolus dose. 
The local anaesthetics injected into epidural space are get absorbed 
initially into epidural veins and are  diluted in the blood.  
 
 
The drug enters into pulmonary circulation where the lungs act as a 
temporary buffer in the view of protecting other organs from the toxic 
effects of local anaesthetics. The local anaesthetic is redistributed to vessel 
rich organs,then to the muscles and fat. 
Long acting amide local anaesthetics are bound to alpha-1acid 
glycoprotein, which binds to the local anaesthetics in high affinity and are 
metabolised in liver and eliminated through renal excretion. 
Distribution:  
Lignocaine binds to α1 acid glycoprotein(70%), and the volume of 
distribution is 91 litres.  
Triphasic distribution of Lignocaine –  
I. Alpha phase (Rapid distribution phase) drug is distributed to 
highly vascularised region. 
II. Second phase Beta phase (slow disappearance phase) drug is 
distributed to solely equilibrating tissues with t ½ 9.6 minutes. 
III. Last is delta phase (slow transformation and excretion phase) 
where the  t½ is 1.6 hours with clearance of 0.95 litre per 
minutes. 
 
 
 
 
Metabolism and Excretion:                                                                         
 Lignocaine is metabolised in liver into monoethylglycinexylidide 
followed by hydrolysis of this metabolite to xylidide. Biotransformation of 
lignocaine in liver includes oxidative N- dealkylation, Ring hydroxylation, 
cleavage of the amide linkage and conjugation. 
The metabolite has prolonged elimination  half time.  75% of 
xylidide excreted in the urine as 4-hydroxyl 2,6 dimethylalanine. 
Monoethylglycynexylidide has approximately 80% of lignocaine cardiac 
protective activity. In liver dysfunction and pregnancy induced 
hypertension elimination half time is prolonged.Metabolism depends on 
hepatic blood flow.Lignocaine crosses the blood brain barrier presumably 
by passive diffusion. 
Elimination half –life of this agent is typically 1.5-2 hours.Peak 
blood level of the drug may occur 5 to 30 minutes. 
At a concentration of 1 to 4 microgram free bases per milliliter, 
arooud 60 to 80 percent of drug is protein bound which is determined by 
plasma concentration of alpha-1 glycoprotein. 
 
 
 
 
Potency: 
Lignocaine has rapid onset of action. Myelinated A delta fibres and 
Non meylinated C fibre are blocked by same concentration of local 
anaesthetics.Preganglionic B fibres are more readily blocked by local 
anaesthetics.Lignocaine has rapid onset of action, for conduction blockade 
small nerves it is 5-10 min and for larger one  10-15 minutes and for I.V 
lignocaine  1-2 minutes. Topical application onset vary with percentage of 
available Lignocaine. 
The potency of a local anaesthetic is affected by several factors 
including Hydrogen ion balance, Fibre type size and myelination,Vascular 
uptake, Proximity to nerve to be blocked, pH of the environment (acidic 
pH antagonise the local anaesthetic action). 
Hypokalemia and Hypercalcemia antagonise the action of 
lignocaine. 
Pharmacodynamics: 
Lignocaine inhibits the sodium channel in peripheral nerves. It prevent 
impulse conduction.It has membrane stabilising property in cardiac tissues.  
It prolongs the phase IV depolarisation thereby it depresses the 
myocardial automaticity, contractility and conduction.  
 
                                      
 
 
It is clinically used as antiarrythmic agent to depress ectopic foci 
and  also cause bradycardia and hypotension due to vasodialation effect on 
vascular smooth muscle. 
 Intravenous lignocaine cause bronchial smooth muscle relaxation 
and bronchodialation. It prevent reflex bronchoconstriction followimg 
intubation.It depress the ventilatory response to hypoxia also depress 
medullary respiratory highercenter.  
Lignocaine has CNS excitatory property. It decreases cerebral blood 
flow thereby reducing intracranial tension following intravenous 
administration.Also it reduces the MAC value of Inhalation agent. 
Indication: 
I. Used for local anaesthesia by infiltration . 
II. Regional anaesthesia used in spinal anaesthesia, Epidural 
anaesthesia, Intravenous Regional anaesthesia, Nerves and Plexus 
block . 
III. Treatment and  prophylaxis  for  life  threatening  ventricular 
arrhythmias.  Lignocaine is class I B anti arrhythmic agent . 
IV. Used in Digitalis toxicity and used following resuscitation from 
cardiac arrest. 
V. Supress  sympathetic stimulation following intubation. 
 
 
 
Contraindication: 
I. History of Allergy or hyper sensitivity to Amide type local 
anaesthetics. 
II. Severe degree of sinoatrial ,Atrioventricular or Interventricular 
block. 
III. CNS infection like meningitis, syphilis, polomyelitis, cranial or 
spinal haemorrhage.  
IV. Tuberculosis or metastaic   lesions of spinal cord.      
V. Patients with severe shock.             
VI. Impaired coagulopathy state for regional anaesthesia . 
VII. Myastheniagravis 
Drug interaction: 
Lignocaine should be cautiously used in patients takingantiarrythmic 
drugs since it potentiate the anti arrhythmic property.Beta antagonists and 
cimetidine  reduces the clearance of inrtavenous lignocaine. 
Phenytoin and lignocaine has additive cardiac depressant activity. 
Fluoxamine drastically reduces the elimination of lignocaine. It reduces the 
Minimum alveolar concentration of Inhalation agents. Prolongs the 
skeletal muscle relaxant action. 
Acute severe alcoholic intoxication centrally depress the 
cardiovascular system thereby reducing the elimination half time.  
 
 
Dose:Recommended maximum dose as plain lignocaine is 3 mg/ml with 
adrenaline (1:2,00,000) 7mg/kg. For reflex suppression 1.5mg/kg 
Inravenously 60 minutes prior to intubation. 
Toxicity:  
Reactions due to overdose with lignocaine are systemic 
manifestation.It involve the central nervous system, respiratory system and 
cardiovascularsystems.Toxicity lead to medullary depression lead to 
respiratory arrest, tonic and clonic convulsions and cardiovascular 
collapse.Cicumoral numbness manifests at 4µg/ml of blood ,convulsion 
occur at 10µg/ml,coma occur at 15µg/ml,respiratory depression occur at 
20µg/ml,cardiovascular collapse occur at 25µg/ml of blood.In unconscious 
patient cardiovascular collapse may be the initial manifestation. 
Treatment: 
 Patency of airway and adequacy of ventilation must be ensured. 
For convulsion small incremental dose of Diazepam or an ultra short 
acting barbiturates like  Thiopentone  should be given. If the patient is 
anaesthetised short acting  muscle relaxant should be given. 
For cardiac toxicity Blood pressure should be maintained with 
adequate intravenous fluid administration and vasopressors. 
Continuous monitoring  for early identification of  toxicity. 
 
 
Adrenaline Effects in the Epidural Space and Spinal cord Blood flow: 
Adrenaline at a concentration of 5miccrogram/ml is added local 
anaestheticsto decrease the absorption. In 1:2,00,000 dilution  dose of 
adrenaline will  reduce the peak blood concentration level of lignocaine 
irrespective of route of administration.Benefits of delayed absorption of 
drug systemically decreases the drug toxicity, increased neuronal 
uptake,improve quality of analgesia and  prolonging the  duration of 
lignocaine. 
To prepare 5 microgram/ml concentration of adrenaline the total 
volume of the lignocaine to be administered is divided into half . The 
decimal point moved two places to the left of the divded value. This is the 
amount of adrenaline to be added to the local anaesthetic total volume it 
yield 1:2,00,000 dilution. 
 Another method for adding adrenaline to local anaesthetic 
preparation is followed as 1: 2,00,000 adrenaline concentration is equal to 
5µg/ml. 1mg/ml adrenaline (1:1000) is diluted  in 10 ml Normal saline 
loaded syringe now the concentration is 100µg/ml. 
The total amount of Lignocaine in ml is multiplied with 5 gives the 
amount of adrenaline to be added. 
 
 
 
Vasoconstriction in the spinal cord cannot explain these decreased 
venous concentrations because spinal cord blood flow did not change, thus 
eliminating the possibility of radicular artery or venous plexus constriction. 
 Adrenaline induced prolonged exposure to local anaesthetic 
contributes to increased anaesthetic duration. The local anaesthetic 
peakplasma concentration are lower when adrenaline is added to epidural 
drugs. 
Adrenaline causes increased cardiac output promoting hepatic 
uptake and increased renal blood flow and elimination. Adrenaline has 
high volume of distribution due to increased capacitance. 
The prolongation of anaesthetic effect can also be explained by an 
analgesic effect throughadrenergic stimulation at spinal cord.Adrenaline in 
epidural can produce segmental hypoanalgesia even not mixed with local 
anaesthetics. 
 
 
 
 
 
 
 
 
 
PHARMACOLOGY OF DEXMEDETOMIDINE 
 Alpha2-agonist areused in anaesthesia and critical care in recent 
years because it not only act as sympatholytic agent and reduces stress 
responses to anaesthesia and surgery but also reduces provide good 
sedation and analgesia.Dexmedetomidinehydrochloride is a selective 
alpha2-agonist. 
It is a 4-((s)-alpha2,3-trimethylbenzyl)  imidazole 
monohydrochloride or  4- [(1r)-1-dimethylphenyl) ethyl] -3h -imidazole 
hydrochloride.  
 Dexmedetomidine compared to clonidine is a much more selective 
alpha2-agonist,alpha2/alpha1selctivity of  dexmedetomidine is 1:1620.It 
has selective alpha2- adrenoreceptoragonism especially 2A subtype. 
Dexmedetomidine acts on  this receptor provides more effective sedative 
and analgesic even with  relatively higher dose  without unwanted vascular 
effect. 
It is used as a short term sedative analgesic in Intensive care unit for 
less than 24 hours.  
Reversal drug for its sedative effect is Atipamezole.  These 
properties render dexmedetomidinesuitable agent during perioperative 
period as premedication,as anaesthetic adjuvants for general and regional 
anaesthesia,suitable for postoperative sedative and analgesic. 
 
 
Alpha2 adrenoreceptors are found in peripheral and central nervous 
systems,platelet,liver,kidney,pancreas,eye and vascular smoothmuscles.  
Alpha2-adrenoceptors found in pre synaptic, post  synaptic and extra 
synaptic location . Alpha2- adrenoreceptors are divided into three sub 
types .The sub type A prominent in central nervous system it is responsible 
for sedative, sympatholytic, analgesiceffect.Subtype B found in peripheral 
vasculature.Subtype C found in Central nervous system is responsible for 
anxiolytic effect.The sub type 2A shows an  inhibition effect over the 
calcium channel in the locus ceruleus of the brain stem but the subtype 2B 
shows excitatory effect.  
Mechanism of action : 
In central nervous system presynaptic activation of alpha2A receptor 
in the locus cerulus inhibits the release of Norepinephrine leads to sedative 
and hypnotic effect. 
Locuscerelus is the site of origin for the descending medullospinal 
noradrenergic pathway it an important modulator of nociceptive 
neurotransmission. Stimulationthe receptorinthisarea terminate the 
propogation of pain signals leading to analgesia. Post synaptic activation 
of alpha2 receptor resultsin decreased sympathetic activity leads to  
hypotension and bradycardia.cardio vagal activity  due to augmentation of 
these receptors. 
 
 
At spinal cord level dexmedetomidine stimulate substantiagelatinosa 
on dorsallhorn  and inhibits peripheral nociceptive reception thereby 
inhbits the release of substanceP. 
In peripheral nerve preventing Norepinephrine release.Stimulation 
Alpha2 receptor in blood vessels contraction of vascular smooth muscle. 
Pharmacodynamics: 
Dexmedetomidine induced sleep qualitatively resembles normal 
sleep. The majority of patients are effectively sedated but they are easily 
arousablewhich is the unique feature of dexmedetomidine. 
It  has no direct action on the heart but the cardiovascular changes is 
biphasic with bolus of 1µg/kg initially cause transient increase in blood 
pressure and reflex fall in heart rate in healthy individuals. 
Stimulation of beta receptor following bolus intravenenous 
administration causes transient increase in blood pressure initially.  But in 
rate of infusion this response can be attenuated. 
Presynaptic receptor stimulation lead to decrease in Norepinephrine 
release results in fall in blood pressure and pulse rate. These effect can be 
managed with Atropine, Ephedrine, and adequiate preloading. 
 The respiratory depression caused by dexmedetomidine is much 
less than other sedatives. It also decrease salvation, decreased platelet 
aggregation, inhibit the release of renin, bowel motility is decreased, 
 
 
intraocular pressure is reduced, increased elimination of water and sodium. 
Shivering incidence is decreased by reducing temperature threshold by two 
degree celcius.  
Pharmacokinetics: 
Dexmedetomidine undergoes glucuronidation and complete 
hydroxylation and cytochrome P450 metabolism in liver. 
It has rapid distribution phase with half life of 6 minutes and 
elimination half lifeof 2 hours following intravenous administration.It is 
the active d-isomer of medetomidine. It has volume of distribution of 118 
litres. Dexmedetomidine shows linear kinetics with the infusion rate of 
0.2-0.7 µg/kg/hour for 24 hours in intensive care unit,the effect appear in5-
10 in and reduced in 30 -60 min. 
The average protein binding of dexmedetomidine is 94%. 
Metabolites are excreted in the urine about 95% and in feces 4%.Dose of 
dexmedetomidine should be reduced in hepatic and renal impairment. It is 
available as 100µg/ml.Atipamazole is an antagonist of dexmedetomidine 
act by increasing central norepinephrine.Duration of action is 2 hours. 
Uses in Anaesthesia: 
Dexmedetomidine used as premedication for its anxiolytic,sedative, 
analgesic and sympatholytic properties. 
 
 
 
Inraoperatively it is used  to reduces stress induced sypmathoadrenal 
responses during intubation as well as extubation. 
It potentiates the effects of intra operativeusing  anaesthetic agents 
regardless of route of administration. It is used as sole anaesthetic agent for 
minor surgery. With higher plasma concentration of dexmedetomidine 
decreased muscle force dected by mechanomyography.It decreases opioid 
requirement resulting in more rapid recovery from anaesthesia. Itprovides 
intense analgesia and reduces the needfor painmedication in 
PostAnaesthesiaCareUnit 
Post operative analgesic requirement reduced by 50% in cardiac 
patient dexmedetomidine is associated with lower incidence of shivering. 
In regional anaesthesia it is used as adjuvants in epidural analgesia 
to reduce post operative shivering, used with lignocaine in Inravenous 
regional anaesthesia to improve quality of analgesia withoutcausing side 
effect.It is a powerful antinociceptive effect,mediated at the spinal level. 
Uses in critical care Management: 
Dexmedetomidine has been used in the intensive care for its sedative 
and analgesic properties and does not produce respiratory depression due 
to its non opioid mechanism of analgesia.The dosage of Dexmedetomidine 
is loading dose of 1µg/kg over 10mins and maintainence dosage of 0.2 to 
0.7µg/kg/hr. 
 
 
Dexmedetomidine is diluted in 0.9% normal saline.It is not given as 
bolus dose as it causes paradoxical hypertension.This hypertension due to 
stimulation ofpost synaptic alpha2B stimulation. It is recommended for 
infusion up to 24hours only. Ithas been used continuously as infusion in 
mechanically ventilated patients prior to extuubation, during extubation 
and in  postextubation period. 
 It iscatiouslyused  in  patients with  bradycardia, atrio ventricular  
conduction block, ejection fraction less than 30%, hypotensive, 
hypovolemic. 
Advantages are reduces patient awareness of the environment, 
reduces patient response to external stimuli, facilitates endotracheal tube 
tolerance and ventilator synchronisation. 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHOD 
It is a prospective Randomised study conducted in Goverment Rajaji 
Hospital,Madurai. 
The ethical committee‟s approval was obtained and informed 
consent was obtained from the patient,who were included in this study.  
Inclusion criteria:  
I. ASA Iand  II patients 
II. Age between 35to 65 years. 
III. Both sexes  
IV. Patients posted for lower abdominal surgeries 
Exclusion criteria : 
I. History of allergy to local anaesthetics. 
II. Previous neurological deficit.  
III. Infection at local site 
IV. Height less than 150 cm 
V. Weight more than 120 kg. 
VI. Patents on beta Blockers,Calcium channel blockers. 
VII. Patients with conduction block and arrhythmias. 
 
 
 
 
 
A total of 60 patients were randomnly divided into two groups of 30 each.  
  Group ED received dexmedetomidine through epidural route and   
Group ID received dexmedetomidine through intravenous route . 
Inside theoperation theatre, good Intravenous access was secured 
and the patient was pre loaded with 10 ml/kg of Normal saline. 
The monitors included Spo2, ECG and NIBP.The baseline parameters were 
recorded (Pulse rate,Blood pressure,Spo2,Respiratory rate).  
Patient was put in Right lateral position and epidural was performed. 
With asepsis and antisepsis of the region, L1-L2 space was identified and 
infiltrated with 1% lignocaine at skin level and using 16G  Tuohy‟sneedle 
and LOR syringe epidural space is identified.  
The test dose of 1.5% of 3 ml lignocaine with adrenaline is injected 
to exclude vascular and intra thecal administration.16G catheter threaded 
into the space and tip of the catheter placed at T11 level. Patient turned to 
supine position. 
TheED group received 2% lignocaine with adrenaline at 5mg/kg ( 
5µg of adrenaline for each ml of lignocaine in(1:2,00,000) dilution) The 
adjuvant dexmedetomidine was mixed with local anaesthetic in a dose of 
1µg/kg and administered through the epidural catheter. 
 
 
 
The ID group received 2% lignocaine with adrenaline only through 
the epidural route. Dexmedetomidine was administered through the 
intravenous route in a dose of 1µg/Kgwhich was mixed in 100 ml in 
normal saline and infused over 10 minutes through a seprate dedeicated 
intravenous line 
Following parameters are noted : 
 
a. Time taken for sensory onset T10. 
b. Time of onset of complete motor block. 
c. Level of maximum sensory block. 
d. Time to two segmental regression  
e. Duration of surgery. 
f. Time for rescue analgesia. 
g. Intraoperative sedation score. 
h. Hemodynamic parameters, Blood pressure, Pulse rate, Spo2, 
Respiratory rate. 
i. Complications if any. 
The bilateral pin prick method was used to assess sensory 
blockadelevel and Modified Bromage score was used to asses the motor 
blockade;Score0 for no block ,1for not able to flex the knee ,3 for not able 
to flex ankle and knee used for motor blockade.  
 
 
Sedation was assessed with Ramsay sedation score;1 for patient 
anxious,agitated,restless, 2 for patient is co operative and calm,3 for 
patient responds to oral commands only, 4 for exhibits brisk response to 
loud auditory or light glabellar tap, 5 for sluggish response toglabellar or 
auditory stimulus, 6 for patient exhibit no response .  
Vitals monitoring included  pulse rate, Blood pressure, Spo2, 
respiratory rate for every 2,5,10,15,30,45,60,90,120minutes interval .Fall 
in blood pressure less than 20% from baseline was considered as 
hypotension  and treated with 6 mg ephedrine and fall in pulse rate 
lessthan 50/min was considered as bradycardia and treated with 
Inj.Atropine 0.3 mg.         
   
 
 
 
 
 
 
 
 
 
 
 
OBSERVATION AND RESULTS 
A total of 60 patients undergoing lower abdominal surgeries under 
epidural anaesthesia  is divide into two group contain 30 patients in each 
group .Epidural anaesthesia (ED) 2% lignocaine 5mg/kg with adrenaline 5 
µg/ml with dexmedetomidine 1µ g/kg given in epidural route .Intravenous 
dexmedetomdine (ID) 2%Lignocaine 5mg/kg with Adrenaline  5µg/ml 
given through epidural route dexmedetomidine 1µg/kg given in 100 ml 
Normal saline over10 minutes. 
Data analysis was done with the help of computer using 
Epidemiological Information Package (EPI) developed by centre for 
Disease control,Atlanta.Using this software range, frequencies, 
percentages, means, standard deviation, chi square, and „p‟values were 
calculated .Kruskul Wallis chi-square test was used to test the significance 
of difference between quantitative variablesand Yate‟s chi square test for 
qualitative variables. A „p‟ value less than 0.05 is considered as significant 
relationship and less than 0.0001 as high significant.  
  
 
 
 
 
 
Group ED - Epidural Dexmedetomidine 
Group ID - Intravenous Dexmedteomidine 
 PROFILE OF CASES STUDIED 
Table 1 : Age 
 
Group Age in years 
Range  Mean   SD   
        Group ED  40-64  53.4 6.2 
Group ID 45-65 53.5 5.0 
„p‟value 0.9705  
Not significant 
 
Mean age of group ED was 53.4 years and group ID was 53.5 years 
.There was no significant  statistical difference.(p=0.9705) . 
 
 
 
 
  
 
 
Table 2 : Sex distribution 
 
Sex Group ED Group ID 
No. % No. % 
Male 16 53.3 17 56.7 
Female  14 46.7 13 43.3 
Total  30 100 30 100 
„p‟ 0.7969  
Not significant 
 
53.3% in  Group ED and 56.7% in Group ID were Male. 46.7%in Group 
ED and 43.3% in Group ID were Female .The sex distribution did not have 
any statistical significance. 
 
 
 
 
  
 
 
Table 3 :BMI 
 
Group BMI 
Range Mean SD 
Group ED 20.2 – 27.4 23.2 1.8 
Group ID 16.4 – 36.1 24.4 4.6 
„p‟ 0.2675 
 Not significant 
 
Mean BMI of ED was 23.2 and ID was 24.4. 
The Mean BMI of both groups were not statisticallysignificant 
(p=0.2675). 
 
 
 
 
 
 
 
 
 
 
Table 4 : ASA 
 
ASA Group ED Group ID 
No % No % 
I 17 56.7 19 63.3 
II 13 43.3 11 36.7 
„p‟ 0.7921  
Not significant 
 
ASA I among ED group was 56.7% and ID was 63.3%.ASA II among 
Group ED was 43.3% and ID was 36.7% ASA distribution among two 
groups were not statistically significant with the „p‟ value of 0.7921. 
 
 
 
 
 
 
 
 
 
  
 
 
Table 5 :Duration of surgery 
 
Group Duration of surgery ( in minutes) 
Range Mean SD 
Group ED 90-150 112.5 15.9 
Group ID 60-160 114.3 20.0 
„p‟ 0.6382  
Not significant 
 
Mean Duration of surgery  in ED was 112.5 minutes and in ID was 114.5 
minutes . Duration of surgery  among  two groups were not statistically 
significant.(p=0.6382).  
 
 
 
 
 
 
 
 
 
 
 
EFFICACY OF THE TWO ROUTES 
 
Table 6: Sensory onset at T10 
 
Group Sensory onset at T 10 ( in minutes) 
Range Mean SD 
Group ED 6-10 7.23 1.07 
Group ID 10-15  12.67 1.79 
„p‟value 0.0001  
Significant 
 
Mean duration for sensory onset at T10 level in ED group was  
7.23±1.07 minutes and in the ID group it was 12.67±1.79 minutes  
 
 
 
 
 
 
 
 
 
 
 
Table 7: Level of maximum sensory block 
 
Sensory block level Higher level in 
Group ED Group ID 
No % No % 
T2 - - - - 
T4 24 80 24 80 
T5 3 10 3 10 
T6 3 10 3 10 
T8 - - - - 
T9 - - - - 
 
The highest level of sensory block in  themajority number of   cases in 
both groups was at T4 level. 
 
 
 
 
 
 
 
 
 
Table 8: Time for 2 segment regression 
 
Group Time for 2 segment regression ( in 
minutes) 
Range Mean SD 
Group ED 60-100 83.7 12.3 
Group ID 35-50 43.2 4.3 
„p‟Value  0.0001  
Significant 
 
Mean duration of  two segment regression in ED group was 83.7±12.3 
minutes and in  Group ID it was  43.2±4.3 minutes .This is statistically 
significant bwith a p value of 0.0001. 
 
 
 
  
 
 
Table 9 :Onset of motor block 
 
Group Onset of motor block ( in minutes) 
Range Mean SD 
Group ED 8-14 10.7 1.5 
Group ID 8-15 10.2 1.7 
„p‟Value 0.1218  
Not significant 
 
Mean duration for onset of motor block in ED group was 10.7±1.5 minutes 
and in  ID group was 10.2±1.7 minutes .There is no statistical significance 
between two groups .(p=0.1218).  
 
 
 
 
 
 
 
 
 
 
 
 
Table 10 :Time for complete motor block 
 
 
 
 
 
 
 
 
 
Mean duration for complete motor block was 14.4±1.2minutes in ED 
group and 14.2±1.8 minutes in ID group .There is no significantstatistical 
difference between the two groups. 
 
 
 
 
 
 
 
 
 
Group Time of complete motor block (in 
minutes) 
Range Mean SD 
Group ED 11-16 14.4 1.2 
Group ID 10-18 14.2 1.8 
„p‟value 0.9514  
Not significant 
 
 
 
Table 11 : Time for first rescue analgesia 
 
Group Time for first rescue analgesia 
 (in minutes) 
Range Mean SD 
Group ED 135 - 170 158.1 13.4 
Group ID 60 - 105 69.7 7 
„p‟value 0.0001 
Significant 
 
Mean duration of time for rescue analgesia in ED group was 158.1±13.4 
minutes and in   ID group itwas 69.7±7 minutes.The duration for the first 
rescue analgesic was longer in the ED group when compared to the ID 
group which is statistically significant with a p value of 0.0001. 
 
 
 
 
  
 
 
CHANGES IN VITAL PARAMETERS 
Table 12 : Changes in systolic blood pressure 
The mean systolic blood pressure at 5 and 10 minutes (101.9 ± 6.3 and   
93.6± 4.3)were lower in the ID group when compared to the ED group 
(93.8±  4.6 and  91.7± 3..4) This was statistically significant.But at 15 and 
30  minutes, the mean SBP was lower in the ED group (91.6 ±3.1 
and102.2±4.7) when compared to the ID group (101.9± 6.3  and 105.1 
±5.4) The values are statistically significant.At all other times, the SBP 
was comparable in both the groups. 
 
SBP at 
SBP mmHg „p‟ Significance 
Group ED Group ID 
Mean SD Mean SD 
2 minutes 116.6 9.2 116.9 9.2 0.8787  Not significant 
5 minutes 101.9 6.3 93.8 4.6 0.0001 Significant 
10 minutes 93.6 4.3 91.7 3.4 0.044 Significant 
15 minutes 91.9 3.1 101.9 6.3 0.0001 Significant 
30 minutes 102.2 4.7 105.1 5.4 0.0477 Significant 
45 minutes 111.9 8.1 111.9 8.1  1.0 Not significant 
60 minutes 115.1 8.9 115.1 8.9 1.0 Not significant 
90 minutes 116.7 8.0 117.9 8.9 0.7328 Not significant 
120 minutes 125.6 8.1 124.9 7.4 0.7385 Not significant 
 
 
Table 13 : Changes in Diastolic blood pressure 
 
 
DBP at 
DBP of  „p‟ Significance 
Group ED Group ID 
Mean SD Mean SD 
2 minutes 81.1 7.7 81.1 7.7 1.0 Not significant 
5 minutes 70.6 7.4 67.7 7.5 0.1928 Not significant 
10 minutes 65.5 7.1 64.3 6.0 0.6448 Not significant 
15 minutes 65.5 6.0 71.5 7.3 0.0009 Significant 
30 minutes 68.3 6.0 68.1 6.6 0.7481 Not significant 
45 minutes 72.4 4.9 70.9 5.1 0.2507 Not significant 
60 minutes 72.8 5.2 71.7 4.8 0.4328 Not significant 
90 minutes 71.5 5.3 73.5 5.2 0.1405 Not significant 
120 minutes 74.0 5.0 75.7 5.2 0.1721 Not significant 
 
Mean value for Diastolic Blood pressure in ED grou at 15 minute    65.5 
±6 was significantly lower than ID group at 15 min (71.5±7.3). 
 
 
 
 
 
 
Table 14 : Changes in pulse rate 
 
 
Pulse Rate at 
Pulse Rate of „p‟ Significance 
Group ED Group ID 
Mean SD Mean SD 
2 minutes 97.7 13.5 99.0 13.0 0.7389 Not significant 
5 minutes 69.4 5.9 66.4 5.7 0.0596 Not significant 
10 minutes 69.2 3.6 66.5 3.0 0.0019 Significant 
15 minutes 67.3 4.2 66.6 4.6 0.9349 Not significant 
30 minutes 69.8 6.1 68.6 4.8 0.5049 Not significant 
45 minutes 73.7 5.2 71.7 4.8 0.1108 Not significant 
60 minutes 75.6 4.9 75.1 4.1 0.7665 Not significant 
90 minutes 86.3 4.0 84.8 4.3 0.1124 Not significant 
120 minutes 85.9 4.8 84.7 4.3 0.3214 Not significant 
 
The decrease in pulse rate was comparable in both groups, except at  
10minutes the decrease in pulse rate in ID group was more which is 
statistically significant. 
 
 
 
 
 
Table 15 :Changes in Respiratory Rate 
 
 
Respiratory 
Rate at 
RespiratoryRate of „p‟ Significance 
Group ED Group ID 
Mean SD Mean SD   
2 minutes 15.6 0.8 14.1 0.3 0.0001 Significant 
5 minutes 14.3 0.65 13.7 0.79 0.0038  Significant 
10 minutes 14.17 0.53 13.8 0.61 0.0184 Significant 
15 minutes 14.17 0.46 14.67 0.76 0.0025 Significant 
30 minutes 14.07 0.25 14.33 0.92 0.0318 Significant 
45 minutes 14.03 0.18 13.97 0.41 0.5703 Not significant 
60 minutes 14.13 0.43 14.47 2.01 0.0007 Significant 
90 minutes 14.73 0.78 14.67 1.15 0.2756 Not significant 
120 minutes 15.27 1.01 15.27 1.28 0.9235 Not significant 
 
Respiratoryrate in both ED and ID groups were between 14 and 
16/min. There was no decrease in respiratory  rate noticed through out the 
procedure, but there were statistically significant differences between the 
two groups.  
 
 
 
 
Table 16: Changes in SPO₂ 
 
 
SPO₂ at 
SPO₂ of   
„p‟ 
 
Significance Group ED Group ID 
Mean SD Mean SD 
2 minutes 99.0 0.53 99.0 0.37 1.0 Not significant 
5 minutes 99.0 0.37 99.3 0.6 0.0781 Not significant 
10 minutes 99.0 0.37 99.2 0.71 0.1355 Not significant 
15 minutes 98.97 0.41 99.17 0.65 0.1397 Not significant 
30 minutes 99.0 0.45 98.97 0.41 0.767 Not significant 
45 minutes 98.97 0.41 98.8 0.55 0.1711 Not significant 
60 minutes 98.97 0.49 99.13 0.57 0.2209 Not significant 
90 minutes 99.0 0.37 99.0 0.45 1.0 Not significant 
120 minutes 98.93 0.45 99.2 0.63 0.0945 Not significant 
 
Mean value for SPO₂ throughout the procedure was between 98 and 
99.There was no significantstatistical  difference between ED and ID  
groups  
 
 
                                     
 
 
Table 17 : Sedation Score 
 
Sedation 
Score at 
Sedation Score of   „p‟ Significance 
Group ED Group ID 
Mean SD Mean SD 
2 minutes 1.13 0.35 1.33 0.48 0.0694 Not significant 
5 minutes 1.37 0.49 1.8 0.66 0.0093 Significant 
10 minutes 2.77 0.68 3.1 0.61 0.0477 Significant 
15 minutes 2.7 0.68 3.1 0.65 0.0082 Significant 
20 minutes 2.6 0.5 2.97 0.61 0.0202 Significant 
25 minutes 2.4 0.5 2.53 0.63 0.3372 Not significant 
30 minutes 2.3 0.54 2.43 0.5 0.3539 Not significant 
45 minutes 2.1 0.48 0.233 0.48 0.0736 Not significant 
60 minutes 1.93 0.52 2.17 0.53 0.0908 Not significant 
90 minutes 1.63 0.56 1.8 0.55 0.2458 Not significant 
120 minutes 1.5 0.57 1.53 0.57 0.8071 Not significant 
 
The sedation score at 5, 10, 15 and 20 minutes were higher in the ID group 
and it was statistically significant. At all other times, the sedation score 
were comparable in both the groups. 
 
 
 
 
Table 18 : Side effects 
 
SIDE 
EFFECTS 
 
NO OF CASES  
„p‟ VALUE 
 
GROUP 
ED 
GROUP ID 
Dizziness 1 0 0.987 
Dry mouth 3 
 
6 0.876 
Shivering 
 
1 0 0.562 
Respiratory 
depression 
0 0 0 
Nausea 2 3 0.591 
Hypotension 4 5 0.560 
Bradycardia 3 6 0.876 
 
The incidence of side effects like dizziness, shivering ,head ache , 
dry mouth, nausea, hypotension and bradycardia were comparable in both 
groups and were statistically insignificant. 
 
 
REVIEW OF LITERATURE 
1)   Dexmedetomidine for the prevention  of shivering during spinal 
anaesthesia. Clinics. 2011 July; 66(7): 1187–1191.  BurhanettinUsta, 
MuhammetGozdemir,Demrcioglu,BunyaminMuslu,HuseyinSertand  
Andan Yaldiz. This study is conducted to evaluate the efficacy of 
dexmedetomidinein  the control of  shivering during spinal anaesthesia 
with  hyperbaric bupivacaine for elective minor surgeries. The results were 
the intensity of shivering was lower in dexmedetomidine group than saline 
group. The time from baseline to onset of shivering 10 min in group 
dexmedetomidine whereas 15 min in group saline. It has been concluded 
that Intravenous dexmedetomidine infusion is effective in the prevention 
of shivering and moderate sedation in patients undergoing  spinal 
anaesthesia. 
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epidural bupivacaine and epidural clonidine plus bupivacaine in lumbar 
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Niyogi S, Santra S, Chakraborty J, Chakraboty S, Mandal S. Department 
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prospective double blind placebo controlled study for patient undergoing 
laminectomy under general anaesthesia. 
They have concluded that no clinically significant difference was 
found between two groups in pulse rate, Mean arterial pressure, respiratory 
rate, Spo2, and motor block but adding small amount of alpha 2 agonist as 
an adjuvant in epidural route with bupivacaine providing better sedation 
and prolong  post operative analgesia and improved patent satisfaction 
without any side effects. 
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Salgado PF, SabbagAT, Silva PC BrienzeSL, DaltoHP, Braz JR, Modolo 
NS.This study aimed to evaluate clinical characteristics of 
epiduralanesthesia performed withropivacaine added with 
dexmedetomidine. The results of the study showsthatepidural 
dexmedetomidine had no effect on onset time and upper level for sensory 
analgesia  but  it prolonged sensory  block duration significantly Motor 
block intensity and duration increased and also post operativeanalgesia. 
Values of bispectral index were lower in epidural dexmedetomidine group. 
There was no difference in incidence of hypotension and bradycardia. 
Incidence of side effects including shivering, vomiting, and decreased in 
spo2 values less than 90% were low. 
 
 
4)    Comparative evaluation of Dexmedetomidineand  fentanyl for 
epidural analgesia in lower limb surgeries Saudi Journal of anaesthesia 
2011 october ;5(4): page 365- 370.  
BajawaSJ ,Arora V, Kaur J, Singh A, Parma S S.  This study aimed 
at   to  compare the hemodynamic, sedative, and analgesia potentiating 
effects of epidural  fentanyl and dexmedetomidine with ropivacaine. . The 
results shows that the onset of sensory analgesia at T10 (7.12±2.44vs 
9.14±2.94) and the time for complete motor blockade (18.16±4.52 
vs22.98±4.78) was significantly earlier in the 
Ropivacainedexmedetomidine group. Post operative analgesia was 
prolonged significantly in the ropivacaine and dexmedetomidine group. 
(366.62±24.42) and low consumption of local anaesthetics (76.82±14.28vs 
104.35±18.96) during epidural top ups post operatively.  Sedation scores 
were better in ropivacaine and dexmedetomidine group.  It was statistically  
significant on comparison. Occurance of nausea and vomiting was 
significantly high in ropivacaine and fentanyl group but drynessof mouth is 
significantly high in RD group. (p<0.05).It has been concluded that 
dexmedetomidine seems to be a better alternative to fentanyl as an epidural 
adjuvant.It provides better stable hemodynamics, early onset of sensory 
block, prolonged post op analgesia, lower requirement of post operative 
local anaesthetics for epidural analgesia and better sedation score.  
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under Epidural anaesthesia. Agri 2010 July;22(3) page-121-30. 
Kuzucuoglu T, Bolukbasioglu I, Arslan G, Yuce E,  Ayaz B , 
Dr.LutfiKidar.They conducted a study to assess the sedative effects of 
midazolam and dexmedetomidine and hemodynamic stability under 
epidural anaesthesia.Result shows that in dexmedetomidine group, mean 
arterial pressure was significantly higher and pulse rate was significantly 
lower than in midazolam group. It has been concluded that both drugs 
provided good sedation without respiratory depression, stable 
hemodynamics and alertness with good patient cooperation. 
 
6) Effect of Dexmedetomidine on duration of anaesthesia and wakefulness 
in Bupivacaine epidural Block. 
Europian Journal of Anaesthesiology 2007 Jun;24(6):535-40. 
E pub 2007 Jan 23.Coskuner I, TekinM, KatiI, YagumurC, Elcicek 
K. Yagumur C. They conducted a study to assess the effects of 
Intravenous dexmedetomidine  in prolonging the duration of epidural 
anaesthesia with bupivacaine and level of sedation  and  sideeffects 
compare to saline group.  
 
 
 
 
60 patients in ASA I and II  were included in the study.They were divded 
into two groups.The results of the study shows that the duration  of sensory 
analgesia was significantly longer, decreased  heart rate was significantly 
lower in the dexmedetomidine group. The bispectral index values were 
lower in the dexmedetomidine group than in the saline. 
Conclusion is  intravenous  route  of dexmedetomidine prolonged the 
duration of epidural anaesthesia, provided sedation with few sideeffects. 
7)  Dexmedetomidine and clonidine in epidural anaesthesia            
     A comparative evaluation. BaiwaSJ, Baiwa SK, Kaur J, AroraV, Gupta 
S, Kulshrestha A, Singh A, Parmar S Singh G ,Gorava S. 
Indian Journal of Anaesthesiology March 55(2) page 116-121. 
This study conducted  to compare the clinical profile and efficacy of 
dexmedetomidine and clonidine in epidural anaesthesia.It has been 
concluded that sedation score with dexmedetomidine group is significantly 
higher than clonidine group (P< 0.05). Regarding the side effectsof  both 
groups  shows that there were  incidence of nausea and dry mouth was 
noticed but not statistically significant. Dexmedetomidine is a better 
epiduraladjuvant compared to clonidine for providing early onset of 
sensory block, better sedation during intra operative period and prolong 
post operative analgesia.  
 
 
 
8)    Epidural anaesthesia with Intravenous dexmedetomidine sedation in 
the successful anaesthetic management of MRI- guided focused ultrasound 
ablation of early prostatic cancer.  NgAT, JP Yam PC. Journal of 
Anaesthesiology 2011 october 25(5) page 756 -759  
In this report patients posted for MRI guided focused ultrasound ablation 
of prostatic cancer taken under epidural anaesthesia with intravenous 
dexmedetomidine. It provides better sedation score without causing 
respiratory depression or hemodynamic instability and also useful in 
preventing shivering.. 
9)   Dexmedetomidine as an adjuvant to ropivacaine prolongs peripheral 
nerve Block. D Marhofer , S.C. Kettner , S.Pills, M.Weber and  M 
Zeilliger. They conducted this study in volunteers to assess efficacy of 
adding Dexmedetomidine with ropivacaine in peripheral nerve block 
versus systemic administration of  dexmedetomidine in peripheral nerve 
block by Ropivacaine .It has been concluded that profound prolongation of 
nerve  block was noticed  if dexmedetomidine  added with ropivacainethan  
systemic administration of dexmedetomidinebut no difference notified in 
onset of sensory block but motor block onset  is faster in ropivacaine with 
dexmedetomidine group .  
 
 
 
 
10)  Epidural Dexmedetomidine in regional anaesthesia to reduce anxiety.  
SA oriole –Lopez,  A Maldono- sanchez , CE Hernandez- Bernal, JA 
Castelazo-Arredono , L Moctezuma . Revista Mexicana de Anestesiologia 
vol.31 No.4 october-Dcember2008 :page  271-277. 
The use of dexmedetomidine as adjuvant with lignocaine given in epidural 
for regional anaesthesia with adrenaline give the sedation score of 3 at 5 
min, 3-4 at 15 to 90 min in majority of population. All patient were 
hemodynamic  stablewithout respiratory depression. 
11)  Intravenous Dexmedetomidine prolongs Bupivacaine spinal 
anaesthesia not midazolam. 
Canadian Journal of anaesthesiology (2010) 57 page-39-45. 
In this randomized double  blind clinical study and a comparison was made 
with midazolam to assess the effect of intravenous dexmedetomidine as  
premedication on spinal anaesthesia duration as well as on sedation and 
post operative analgesia.Results shows that in Dexmedetomidine group 7 
patients out of 25 required analgesia in first post operative day 
significantly  less than placebo group 16 patients required analgesia and in 
midazolam group 15 patients require analgesia  (p<0.05).  
 
 
 
 
12)   Intravenous dexmedetomidine prolongs Bupivacaine spinal 
anaesthesia. M.E.J.Anaesthesia 2009:20(2).  
Supplementation of spinal anaesthesia with intravenous dexmedetomidine 
produces significantly longer sensory and motor block than spinal 
analgesia alone. All patient reached better sedation levels that enabled 
patients cooperation and better operating conditions for the surgeon 
without respiratory depression.  
 13)  Effect of epidural demedetomdine on intraoperative awareness and 
post operative pain after one lung ventilation. Acta anaesthesiologyScand 
2010 Jul 54 (6) page 703-709. Elhakin M, Abdelfattach H  
Abdelhamid D,ElshafeiM ,Elsayed A. During combined regional and 
General anaesthesia they compared the effect of a dexmedetomidine 
bupivacaine mixture with bupivacaine for thoracic epidural anaesthesia. 
Results showed that there was a limited decrease in PaO₂ at one lung 
ventilation in dexmedetomidine group  compare with plain bupivacaine 
group.They concluded that the use of epidural dexmedetomidine as an 
adjuvant in epidural in general anaesthesia the requirement for anaesthetic 
drug dose reduced significantly, also produce unawareness state during 
surgery and prolong post operative analgesia thereby improve 
oxygenation. 
 
 
 
DISCUSSION 
The introduction of dexmedetomidine has fascinated anaesthetist 
due to its wide uses in the field of anaesthesia. Its route of administration  
and its  qualities like analgesic, sedative without causing respiratory 
depression. Using dexmedetomidine as an alternative to opioid  in epidural 
routeto  avoid  respiratory depression , pruritis and  urinary retention. 
Clonidine has been used in past  in regional anaesthesia  as  an adjuvant to 
local anaesthesia due to its faster onset of action , duration of 
analgesia,dose sparing effect and its hemodynamic stability and its efficacy 
is comparable with dexmedetomidine which is a  more selective  alpha2 
agonist. Following administration of drug through epidural route it 
effectively inhibits the transmission of nociceptive impulse at spinal cord 
level  from peripheral surgical stimulation. 
It causes sedation,analgesia and improve the quality of epidural 
anaesthesia. Intravenous administration of dexmedetomidine has its 
supraspinal effect due to its inhibitory action over locusceruleus.The nor 
adrenergic innervation of the spinal cord arise from the noradrenergic 
nuclei present in the brain stem activity.so, the disinhibition of the 
noradrenergic nuclei lead to descending inhibitory effect on spinal cord 
thereby prolongs the sensory  block duration rather than motor block. 
 
 
In  this study the efficacy of dexmedetomidine is compared between 
two routes of administrations; the epidural route and the intravenous 
route.The mean age ,sex distribution,the BMI, the ASA classification and 
the duration of surgery were comparable in both groups and there was no 
statistical difference between two groups. 
The sensory onset time was shorter in the ED group and the highest 
level of sensory block in both group was T4 level and the lowest level in 
ED group was at T6 and in ID group it was at T9.       Compare to 
Intravenous  route (12.67±1.79) epidural route(7.23±1.07) has significant 
earlier onset of sensory block with the  „p‟ value of 0.0001.Results for 
onset and  duration of sensory analgesia correlated with the study 
conducted by Bajawa S J, Arora V in Saudi journal Anaesthesia 
2011.Regarding Motor block is assessed by Modified bromagescale.The 
motor block onset and  duration are compared  between two groups  did 
not have statistical significance  with „p‟value of  0.1218. but,this results 
being differ from the published results in SJA 2011.Probably due to the 
conduction of sensory fibre may be more inhibited than motor fibre. Mean 
duration time for   two segmental regression in ED group (83.7±12.3)was 
statistically significant than  ID group(43.2± 4.3) with the „p‟ value of 
0.0001. 
 
 
Kuzucuoglu in Agri, July 2010 states that intravenous 
dexmedetomidine as premedication for regional anaesthesia prolong 
sensory block but the results is not superior to epidural route. 
Intraoperativelyalthough  thesystolic blood pressure fall occur in 
both group earlier fall with Intravenous administrated group later  fall in 
blood pressure with  epidural route administration.The results were 
statistically significant. Probably due to  decreased sympathetic activity 
and circulating levels of catecholamines. Regarding Diastolic blood 
pressure significant difference shown at 15 min withlower diastolic blood 
pressure in epidural dexmedetomidine. 
The decrease in pulse rate in ID group was more than ED group at 
10 min which is stasticallysignificant.Bradycardia was treated in 6 patient 
with Atropine 0.3 mg  in patients under ID group comparable with ED 
group but not significant. 
Sedation was assessed with Ramsay sedation score graded from 1 to 
6. Most of the patient fell between 2 and 3 grade easily arosable with oral 
commands. Sedation score significantly higher in Intravenous group 
between 5 and 20 minutes.  
 
 
 
Epidural anaesthesia for lower abdominal surgeries reduces 
endocrine and metabolic changes due to surgical stress than upper 
abdominal surgeries. Dexmedetomidine in a concentration producing 
significant sedation retains the ventilatory response to increasing carbon-
di-oxide.A frequently reported side effect of demedetomidine is dry mouth 
due to decreased saliva production.The changes in ventilation appear to be 
similar to those observed during natural sleep.The beneficial effect on 
myocardial oxygen balance has been shown to decrease myocardial 
ischemia and infarction in cardiac as well as non cardiac surgery. The 
probability of respiratory depression using anxiolytic is decreased in these 
patient but level of sedation is achieved with arousable sleep. 
 
 
 
                               
 
  
 
 
 
 
SUMMARY 
This study was conducted in  60 patients undergoing lower 
abdominal surgeries under epidural anaesthesia.These patients  are divided 
into two groups with 30 patients in  each group between 35 and 65 years 
assessed under ASA I and II.   
Group ED- Epidural route administration of 2%lignocaine 5mg/kg 
with Adrenaline 5µg/ml and Dexmedetomidine 1µg/kg  
Group ID- Intravenous route administration of Dexmedetomidine 
1µg/kg with Epidural route administration of 2% lignocaine 5 mg/kg with 
Adrenaline 5µg/ml.This study shows epidural route of administration of 
dexmedetomidine provides earlier onset of sensory block, time for two 
segment regression was prolonged, time for rescue analgesia is prolonged  
than intravenous route of  administration of  dexmedetomidine. Regarding 
the onset and duration of motor blockade  both the groups had similar 
results. Regarding the sedation observed in the intraoperative period  both 
groups provided sedation but sedation score was higher and statistically 
significant in the ID group at 5, 10,15,and 20 minutes.The Hemodynamic 
stability was similar with both groups. The Incidence of complications like 
nausea,hypotension, bradycardia and  drymouth were similar in both 
groups. 
 
 
CONCLUSION 
  The addition of  dexmedetomidine  as an adjuvant to lignocaine in 
epidural anaesthesia provides better quality of anaesthesia, and   prolongs 
the duration of action of  lignocaine whereas dexmedetomidine when 
administered intravenously provides better sedation  than epidural route.In 
both of the routes either via epidural or intravenously dexmedetomidine  
maintains stable cardio-respiratory parameters and patient comfort. 
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1 PANDIAN 40/M 76809 20.37 I B/lIng Hernia Hernioplasty L1-L2 T11 90 
2 BOOPATHY 45/M 67370 21.66 I B/lIng Hernia Hernioplasty L1-L2 T11 105 
3 SHAHUL 60/M 23415 27.08 II B/L Ing Hernia Hernioplasty L1-L2 T11 90 
4 MUTHUKUMAR 58/M 87965 27.35 I B/ling hernia Hernioplasty L1-L2 T11 120 
5 RAMAN 56/M 23456 25.39 I B/lIng hernia Hernioplasty L1-L2 T11 105 
6 RAMU 54/M 56789 23.66 I B/lIng hernia Hernioplasty L1-L2 T11 120 
7 KALYANASUNDARI 47/F 96896 25.45 I paraumblical 
hernia 
Mesh repair L1-L2 T11 130 
8 GANESAN 56/M 26837 19.14 I B/L Ing hernia  Hernioplasty L1-L2 T11 120 
9 SUSEELA 46/F 38058 16.22 I B/L Ing hernia  Hernioplasty L1-L2 T11 110 
10 PANDEESHWARI 53/F 27058 18.42 II incisional hernia Mesh repair L1-L2 T11 120 
11 PUSHPAM 54/F 86438 16.98 II incisional hernia Mesh repair L1-L2 T11 100 
12 THAVASI 63/F 88269 16.78 I incisional hernia Mesh repair L1-L2 T11 105 
13 BAKKIYAM 60/F 57054 17.3 II B/L Ing Hernia  Hernioplasty L1-L2 T11 120 
14 LAKSHMANAN 56/M 96847 18.9 I B/L Ing Hernia Hernioplasty L1-L2 T11 105 
15 SATHAPPAN 55/M 48389 21.1 I U/L ing.hernia Hernioplasty L1-L2 T11 90 
16 KARUPPUSAMY 55/M 37378 19.77 II B/ling Hernia Hernioplasty L1-L2 T11 90 
17 ALAGAMMAL 52/F 84848 16.88 I incisional hernia Mesh repair L1-L2 T11 100 
18 MAHALAKSHMI 47/F 95326 18.9 I umbilical hernia Mesh repair L1-L2 T11 105 
19 PANDIARAJAN 56/M 86436 19.85 II B/lIng hernia Hernioplasty L1-L2 T11 110 
20 KALIYAMMAL 61/F 23568 24.2 I incisional hernia Mesh repair L1-L2 T11 125 
21 THANGARASU 41/M 23578 23.18 II U/L ing.hernia Hernioplasty L1-L2 T11 120 
22 PANCHAVARNAM 49/F 46778 21.91 II incisional hernia Mesh repair L1-L2 T11 110 
23 KALIYAMMAL 51/F 34677 22.5 II incisional hernia Mesh repair L1-L2 T11 120 
24 AROKYARAJ 60/M 57890 19.2 II B/L ing Hernia Hernioplasty L1-L2 T11 140 
25 KARUPPAIAH 64/M 75435 22.9 I B/L ing Hernia Hernioplasty L1-L2 T11 150 
26 SARATHAMBAL 47/F 65467 21.7 II incisional hernia Mesh repair L1-L2 T11 90 
27 RAJJAMMAL 48/F 56788 20.7 I umbilical hernia Mesh repair L1-L2 T11 105 
28 MURUGAN 54/M 13577 23.7 II B/lIng Hernia Hernioplasty L1-L2 T11 130 
29 SIVACHIDHAMBARAM 56/F 57890 25.4 I incisional hernia Mesh repair L1-L2 T11 140 
30 RAVIRASU 57/M 24677 23.44 II B/L Ing Hernia Mesh repair L1-L2 T11 110 
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7 T4 12 90 10 14 150     
9 T4 14 70 9 15 155 dizziness   
10 T5 15 60 13 14 160 hypotension   
8 T4 16 80 12 16 165     
7 T4 14 90 10 14 160 drymouth, hypotension   
6 T4 12 100 12 15 160 brdy,hypoten   
7 T4 14 85 10 13 170 brady   
7 T4 12 90 9 11 180     
7 T4 12 90 12 15 170     
8 T5 14 100 14 16 160     
6 T4 15 80 10 14 150     
7 T4 16 70 13 16 160 hypotension   
8 T4 12 80 9 12 190     
7 T6 14 70 10 14 170 dry mouth 
6 T4 12 60 12 15 150     
7 T6 12 60 11 16 150 bradycardia   
8 T4 12 65 12 16 150     
7 T4 14 80 10 15 155 shivering    
6 T4 12 90 10 14 165     
6 T6 14 90 10 14 165 hypotension   
7 T4 15 95 14 16 145     
7 T4 16 90 10 14 140     
7 T4 14 90 10 15 135     
6 T4 12 95 10 15 150     
9 T4 12 100 10 14 165 shivering   
9 T4 14 80 10 14 185     
8 T5 15 90 9 13 165     
8 T4 16 100 8 15 139     
6 T4 15 90 10 14 140     
6 T4 14 80 12 14 145     
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126 130 100 96 94 100 104 120 110 86 90 84 74 74 80 76 84 82 
130 126 114 98 90 96 100 102 110 80 96 80 80 76 84 80 78 80 
122 120 110 100 96 96 110 110 114 82 94 76 78 72 80 80 80 82 
120 130 100 98 94 100 102 102 104 82 92 90 80 74 82 82 80 78 
120 110 94 88 90 108 110 110 112 76 80 78 74 76 68 80 80 74 
120 106 96 90 90 96 102 104 102 74 84 74 64 68 70 74 76 72 
126 124 96 88 86 96 112 110 110 72 86 76 64 62 66 70 68 68 
110 112 100 90 90 98 114 114 110 70 84 72 70 66 68 74 66 66 
118 116 110 90 88 94 116 114 114 70 88 70 60 66 66 72 70 70 
116 110 100 90 96 100 116 112 112 70 82 68 58 60 64 66 72 68 
136 122 110 100 96 102 102 106 104 68 80 70 56 60 62 66 70 68 
114 124 100 90 90 104 104 106 116 68 78 64 70 66 64 74 70 62 
128 130 102 96 96 106 108 102 104 70 76 66 70 68 66 76 74 64 
136 140 120 96 94 108 120 110 116 78 74 68 64 60 64 68 72 70 
112 130 100 94 90 102 104 106 128 76 70 60 58 60 64 78 74 72 
132 120 100 94 90 100 118 120 124 74 72 62 60 64 60 74 74 74 
136 100 98 90 86 106 114 116 122 70 70 64 58 58 66 76 76 76 
124 104 90 86 88 110 110 114 120 76 86 68 62 64 70 72 70 76 
122 106 100 88 90 100 100 118 124 78 84 68 64 66 68 68 76 74 
128 108 94 90 90 102 102 116 118 74 70 68 62 64 66 72 76 76 
120 110 98 90 92 110 106 120 114 70 68 66 64 66 68 76 78 74 
130 110 100 96 96 102 110 114 112 70 66 70 68 64 66 70 80 72 
124 120 110 100 94 106 116 118 120 68 84 64 60 62 64 64 70 70 
120 114 104 100 96 98 118 120 122 68 82 78 66 56 68 74 68 70 
140 116 102 98 96 100 120 122 124 72 80 84 56 68 66 70 66 72 
126 118 100 96 94 102 122 124 126 74 86 70 64 60 66 68 66 74 
128 120 100 96 90 104 124 126 128 76 84 70 70 54 68 70 64 64 
126 116 102 94 90 106 122 130 124 80 84 68 56 64 68 64 66 66 
140 110 104 96 90 102 126 132 126 80 82 60 74 78 74 70 70 64 
138 110 102 90 94 112 124 136 130 68 80 62 60 68 62 68 70 66 
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86 102 80 74 70 78 77 78 81 14 14 14 14 14 14 14 14 14 
80 100 82 70 72 80 80 85 80 16 16 14 14 14 14 14 14 14 
82 98 66 70 74 74 85 84 83 14 14 14 14 14 14 14 14 14 
82 110 68 66 70 75 80 86 84 14 14 14 14 14 14 14 14 14 
76 94 62 65 69 74 77 78 86 14 14 14 13 14 14 14 14 14 
74 90 63 68 68 71 79 82 85 16 16 14 14 14 14 14 14 14 
72 112 62 66 66 77 78 80 88 16 16 14 14 14 14 14 14 14 
70 76 69 67 67 78 79 76 86 16 16 14 14 14 14 14 14 14 
70 115 64 69 61 72 78 78 84 16 16 14 14 14 14 15 14 15 
70 104 67 67 65 74 73 73 82 16 16 15 14 15 14 14 14 14 
68 84 68 68 68 75 76 79 87 16 16 14 16 14 14 14 15 14 
68 86 64 67 69 77 78 74 89 16 16 14 14 14 14 14 14 15 
70 104 64 70 63 76 77 75 82 16 16 16 15 14 14 14 14 14 
78 82 72 71 62 79 76 76 83 16 16 14 14 14 14 14 15 15 
76 88 70 72 64 69 74 77 85 16 16 14 14 16 14 14 14 15 
74 96 66 70 61 66 70 78 88 16 16 14 14 14 15 14 14 14 
70 110 63 73 74 64 71 74 89 16 16 14 14 14 14 14 14 15 
76 78 61 71 75 68 72 71 80 16 16 14 15 14 14 14 14 16 
78 96 62 70 64 62 70 79 78 16 16 15 14 14 14 14 14 16 
74 109 68 74 61 63 74 72 89 16 16 14 15 14 15 14 14 16 
70 98 72 70 63 69 71 70 89 16 16 14 14 14 14 14 14 15 
70 104 74 69 69 62 76 78 88 16 16 15 14 14 14 14 14 16 
68 106 75 60 65 61 71 74 87 16 16 14 14 15 14 14 16 15 
68 68 70 63 68 64 70 72 86 16 16 14 14 14 14 14 14 16 
72 112 74 70 64 63 69 74 89 16 16 14 14 14 14 14 14 15 
74 85 72 71 65 62 68 70 90 15 15 16 14 14 14 14 14 15 
76 116 78 63 66 67 62 72 93 16 16 16 14 15 14 14 14 16 
80 115 79 76 69 66 68 69 94 16 16 14 14 14 14 14 14 15 
80 79 74 72 70 65 65 68 92 14 14 14 14 14 14 14 14 14 
68 114 74 74 76 64 66 67 91 16 16 14 15 14 14 14 14 14 
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99 99 99 99 99 99 99 99 99 1 2 2 2 2 2 2 2 2 2 2 
99 99 99 99 99 99 99 100 99 2 2 2 2 2 2 2 2 2 2 2 
100 100 99 99 99 99 99 99 100 2 1 1 3 3 2 2 2 2 1 2 
99 99 99 99 99 99 99 99 99 2 1 1 3 2 3 3 3 3 2 2 
99 99 99 99 99 99 100 99 99 2 2 2 3 3 2 2 2 2 2 2 
99 99 99 99 99 98 99 99 99 2 1 2 4 3 2 2 2 2 2 3 
99 99 99 99 99 99 99 99 99 2 2 2 3 2 2 2 2 2 2 2 
99 99 99 99 99 99 99 100 99 2 1 1 2 2 3 3 3 1 2 2 
99 99 99 99 99 99 99 99 100 2 2 2 3 3 3 2 2 2 2 2 
99 99 99 99 99 99 100 99 99 2 2 2 3 3 3 3 3 2 2 2 
99 99 98 99 99 99 99 99 99 2 1 2 4 3 3 2 2 2 2 2 
99 99 99 98 100 100 99 99 99 2 2 1 2 2 3 3 2 2 2 2 
99 99 99 99 99 99 99 99 99 2 2 2 3 3 3 3 3 3 2 2 
99 99 100 99 99 99 99 99 99 2 2 2 2 2 3 3 2 2 2 2 
99 99 99 99 99 99 99 99 99 2 2 2 2 2 3 2 3 2 2 2 
98 98 99 98 98 100 99 99 99 1 2 2 3 3 3 2 2 2 3 2 
98 98 99 99 99 99 99 99 99 2 2 2 2 4 3 3 3 3 2 2 
98 98 99 99 99 99 99 99 99 2 2 2 4 3 2 2 2 2 2 1 
99 99 99 99 99 99 98 100 99 2 1 1 3 4 3 3 3 3 2 2 
100 100 99 99 100 99 99 99 98 1 2 2 2 4 3 2 2 2 3 2 
100 100 99 99 99 100 99 99 99 2 2 2 2 2 2 3 3 2 2 2 
100 100 98 100 99 99 99 98 99 2 2 2 3 3 3 2 2 2 2 2 
99 99 99 99 99 99 99 99 99 2 1 1 2 3 2 3 3 3 2 2 
98 98 100 99 98 99 98 98 99 2 2 2 3 3 2 2 2 2 3 2 
99 99 99 99 99 98 99 99 99 2 2 2 2 2 3 3 3 2 2 2 
99 99 99 99 99 99 99 99 99 2 2 2 3 3 2 2 2 2 2 2 
99 99 99 99 99 99 99 99 99 2 2 2 3 2 2 2 2 2 2 2 
99 99 99 99 98 99 98 99 99 2 2 2 3 2 3 2 2 2 2 2 
99 99 99 100 99 98 99 98 99 2 2 2 3 3 3 2 2 2 2 2 
99 99 99 99 99 99 99 98 98 2 1 2 3 3 3 3 2 2 2 2 
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1 RAJAPPA 45/M 34556 16.36 II B/L ING HERNIA Hernioplasty L1-L2 T11 100 
2 PANDIYAN 54/M 24454 20.09 I B/L Ing Hernia Hernioplasty L1-L2 T11 115 
3 PANDIAMMAL 47/F 24556 20 II B/L  ing hernia Hernioplasty L1-L2 T11 90 
4 MANIKANDAN 63/M 86656 25.9 I B/L  ing hernia Hernioplasty L1-L2 T11 120 
5 RAKKU 65/F 24545 25.25 I B/L  ingheria Hernioplasty L1-L2 T11 115 
6 RAJESHWARI 49/F 87664 24.1 I B/L  ingheria Hernioplasty L1-L2 T11 120 
7 KRISHNAN 48/M 35678 24.54 II B/L  ingheria Hernioplasty L1-L2 T11 130 
8 MANIMARAN 48/M 75336 27.27 I U/L ing.hernia Hernioplasty L1-L2 T11 120 
9 AROKYAMARY 45/F 96547 16.94 II B/L  ing hernia Hernioplasty L1-L2 T11 125 
10 THNGAPPAN 46/M 97655 17.68 I U/L ing.hernia Hernioplasty L1-L2 T11 120 
11 SUGANTHI 56/F 23445 21 II umbilical hernia Mesh repair L1-L2 T11 100 
12 KANDHAN 55/M 77689 21.33 II U/L ing.hernia Hernioplasty L1-L2 T11 105 
13 SANTHANAM 58/M 24346 19.29 I U/L ing.hernia Hernioplasty L1-L2 T11 120 
14 KALAIVANI 57/F 33434 26.8 II umbilical hernia Hernioplasty L1-L2 T11 60 
15 RAJASEKARAN 52/M 97676 28.5 I U/L ing.hernia Hernioplasty L1-L2 T11 90 
16 MOORTHY 45/M 67678 28.42 I B/L  ingheria Hernioplasty L1-L2 T11 100 
17 DEIVANAI 63/F 34454 24.01 II incisional hernia Mesh repair L1-L2 T11 100 
18 NACHIAPPAN 61/M 97676 25.8 I U/L ing.hernia Hernioplasty L1-L2 T11 105 
19 KALYANI 60/F 12233 36.11 II incisional hernia Mesh repair L1-L2 T11 110 
20 SANTHOSAM 60/M 34556 25 I U/L ing.hernia Hernioplasty L1-L2 T11 130 
21 KARTHIKA 50/F 97876 34.73 I incisional hernia Mesh repair L1-L2 T11 160 
22 BASKAR 50/M 86676 28.98 I U/L ing hernia Hernioplasty L1-L2 T11 110 
23 VIRUMANDI 50/M 76454 27.82 II UL ing hernia Hernioplasty L1-L2 T11 120 
24 VIJAYALAKSHMI 52/F 86545 25.2 I incisional hernia Mesh repair L1-L2 T11 140 
25 MANI 51/F 54544 25.85 I incisional hernia Mesh repair L1-L2 T11 140 
26 NAGARAJ 49/M 75654 26.11 II U/L ing.hernia Hernioplasty L1-L2 T11 90 
27 MUNUSAMY 53/M 54433 21.42 I B/L  ingheria Hernioplasty L1-L2 T11 105 
28 POONGATHAI 58/F 34343 20.86 I incisional hernia Mesh repair L1-L2 T11 130 
29 PAZHANI 57/M 97876 23.1 I U/L ing.hernia Hernioplasty L1-L2 T11 150 
30 SAKTHI 58/F 64545 22.65 I incisional hernia Mesh repair L1-L2 T11 110 
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10 T4 14 35 8 10 60     
11 T4 15 40 10 14 65 hypotension   
15 T5 18 45 9 14 70     
10 T4 14 50 12 15 65 brady,hypotens
ion 
  
11 T4 15 45 10 15 60 dry mouth    
13 T4 16 40 10 15 80     
14 T4 18 40 10 15 105 dry mouth   
14 T4 18 45 9 12 60 bradycardia   
14 T4 18 45 8 12 70     
12 T5 16 50 9 12 80     
15 T4 19 35 10 15 90 hypotension   
15 T4 18 40 10 15 60 hypotension   
15 T4 18 40 12 16 60     
14 T6 18 40 12 16 60 dry mouth    
12 T4 16 45 8 12 65 bradycardia   
14 T6 18 45 9 12 70     
14 T4 18 40 10 15 70     
10 T4 15 45 10 15 75     
15 T4 18 45 10 15 80 bradycardia   
11 T6 15 45 12 16 85 bradycardia   
12 T4 15 50 15 18 75 drymouth   
12 T4 15 50 13 16 70     
14 T4 18 50 12 16 80     
12 T4 16 45 12 16 70     
15 T4 18 40 9 12 60     
10 T4 15 40 10 15 60     
12 T5 15 40 8 12 60 brady,hypotens   
10 T4 15 40 9 15 65 drymouth   
12 T4 16 40 10 14 60 drymouth   
12 T4 16 45 9 12 60     
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130 94 90 100 102 118 120 120 122 72 58 60 60 64 66 64 70 70 
120 94 90 100 100 114 116 122 132 70 60 62 62 56 60 72 70 78 
100 90 86 98 106 110 114 116 136 86 58 58 64 66 70 74 72 76 
104 88 88 90 110 100 118 120 124 84 60 64 68 68 74 74 74 74 
106 88 90 100 100 102 116 120 122 70 64 66 68 66 76 76 76 70 
108 90 90 94 102 106 120 124 128 68 66 64 68 64 72 70 76 76 
110 90 92 98 110 110 114 112 120 66 64 66 70 62 68 76 74 78 
110 96 96 100 102 116 118 120 130 84 68 60 72 60 72 76 76 76 
120 100 94 110 106 118 120 122 124 82 60 62 64 60 74 78 74 70 
114 98 96 104 106 120 122 126 126 80 66 56 78 64 70 72 80 80 
116 98 96 102 100 122 124 126 140 86 70 68 84 70 64 70 74 68 
118 102 94 100 102 124 126 128 126 84 70 60 82 72 74 68 70 70 
120 96 90 100 104 122 130 134 130 84 70 54 80 68 70 66 72 72 
116 94 90 102 106 126 132 132 130 82 70 64 68 62 68 66 74 74 
110 96 90 104 106 124 136 138 140 80 74 56 66 70 70 64 66 76 
110 90 94 102 112 104 120 110 126 90 70 68 70 72 64 66 66 80 
126 96 94 100 100 100 102 110 128 96 80 74 72 70 72 70 64 80 
120 98 90 114 116 110 110 114 122 94 84 76 80 84 80 70 82 88 
130 100 96 110 112 102 102 104 124 92 82 72 86 88 80 80 78 86 
110 98 94 100 100 110 110 112 116 80 80 74 90 62 66 78 82 80 
106 90 88 94 108 102 104 104 114 84 74 76 72 70 80 80 84 82 
124 90 90 96 96 112 110 110 116 86 66 68 74 74 80 80 80 82 
112 86 86 96 96 114 114 112 114 84 64 62 70 70 70 68 72 74 
116 90 90 100 102 116 114 116 118 88 70 66 72 74 74 76 68 76 
110 90 88 110 112 116 112 112 118 82 60 58 70 72 68 68 66 74 
122 90 96 100 100 102 106 108 116 80 58 60 68 66 68 66 70 70 
124 102 96 110 110 104 106 116 126 78 56 60 64 66 68 70 68 72 
130 88 86 100 104 108 102 104 114 76 72 66 70 68 66 72 74 76 
140 96 96 102 106 120 110 116 128 74 70 68 66 70 70 70 76 78 
126 96 94 120 116 104 106 128 136 70 68 60 68 66 74 70 78 66 
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112 74 70 66 75 76 76 87 82 14 14 14 15 14 14 14 14 14 
100 68 66 64 69 70 75 84 85 14 14 14 14 14 14 14 14 14 
105 66 62 54 66 71 75 82 84 14 14 14 14 14 14 14 14 14 
110 68 66 74 64 68 74 83 86 14 14 14 14 14 14 14 14 15 
106 58 66 70 70 70 74 85 81 14 14 12 16 14 14 14 14 15 
100 63 71 66 64 70 71 78 78 15 14 14 15 14 14 15 14 15 
112 62 64 66 63 66 79 81 75 14 12 14 15 12 14 15 14 16 
78 60 66 63 69 76 72 80 79 14 14 14 15 14 14 15 14 16 
110 64 68 70 62 71 70 78 85 14 14 14 14 14 14 15 14 16 
108 67 69 65 61 65 70 89 85 14 14 14 14 14 14 15 14 16 
84 68 60 68 66 69 74 76 87 14 14 14 14 14 12 15 15 19 
74 64 63 66 63 68 72 78 84 14 14 14 16 15 14 15 14 18 
104 64 68 65 62 62 74 84 88 14 15 12 14 16 14 14 14 15 
82 60 71 70 67 68 70 86 85 14 12 14 16 16 14 16 15 14 
98 70 63 58 66 65 72 89 86 14 14 14 14 16 14 16 14 14 
96 60 70 70 65 66 69 90 89 14 14 14 15 15 14 16 16 15 
110 63 66 72 64 68 68 78 80 14 12 14 16 15 14 16 14 16 
78 59 70 71 78 79 80 94 97 14 14 14 14 15 14 15 18 14 
96 58 66 72 76 80 78 86 85 15 14 14 14 15 14 14 14 15 
109 64 70 74 76 80 85 86 88 14 14 14 14 15 14 15 18 18 
98 70 64 70 74 77 79 81 85 14 14 14 14 15 14 16 14 15 
104 72 66 69 74 76 80 84 86 14 14 14 15 15 15 14 16 16 
106 70 65 68 70 78 78 83 84 14 12 14 15 14 14 15 14 15 
70 64 68 66 69 70 82 84 85 14 14 14 15 14 14 16 15 14 
112 66 66 67 70 74 80 86 90 14 14 14 15 14 14 16 14 15 
88 72 67 60 72 73 74 80 84 14 14 14 16 14 14 15 16 14 
110 78 69 64 70 74 78 84 88 14 14 14 15 14 14 14 16 14 
112 74 67 66 69 70 73 76 77 14 12 14 14 14 14 12 14 15 
85 66 60 65 73 75 76 84 89 14 14 12 14 12 14 5 15 15 
112 80 67 60 72 75 75 80 83 14 14 14 14 14 14 14 14 16 
 
 
 
 
 
 
 
SpO2                                                     SEDATION SCORE 
2 
Min 
5 
Mins 
10 
Min 
15 
Min 
30 
Min
s 
45 
Min
s 
60 
Min
s 
90 
Min
s 
120 
Min
s 
2 
M
in 
5 
Mi
ns 
10 
Mi
n 
15 
Min
s 
20 
Mi
ns 
25 
Mi
ns 
30 
Mi
ns 
45 
Mins 
60 
Mins 
90 
Mi
ns 
120 
Mins 
99 99 99 99 99 99 99 99 98 2 2 3 3 3 2 2 2 2 2 1 
99 99 99 99 99 99 99 99 100 1 2 3 2 2 2 2 2 2 2 1 
99 99 100 98 99 99 99 99 100 2 2 4 4 2 2 2 2 2 2 2 
99 99 99 99 100 98 98 98 99 2 2 3 3 3 3 3 3 2 2 1 
99 99 99 98 99 99 99 99 99 1 2 3 3 2 2 2 2 2 2 2 
99 100 99 99 99 99 100 99 100 2 2 4 4 4 3 2 2 2 2 2 
99 100 100 99 99 99 100 99 99 2 2 3 3 4 2 2 2 2 2 2 
99 99 99 99 99 99 99 99 99 1 2 2 2 3 3 3 3 2 2 2 
99 99 99 99 99 100 99 100 99 2 2 3 3 3 3 3 3 2 2 2 
99 100 99 100 98 99 99 99 100 2 2 3 3 3 3 3 2 3 2 2 
100 98 100 100 99 99 99 99 100 1 2 4 4 3 2 2 2 2 2 2 
99 100 100 99 99 98 100 99 99 2 3 3 3 2 3 3 2 2 2 2 
99 99 98 99 99 98 98 98 99 2 3 3 3 3 3 3 3 2 2 2 
99 99 98 99 99 99 99 99 100 2 2 2 4 4 4 3 3 2 2 2 
99 100 100 100 99 98 99 99 98 2 2 2 3 3 2 3 2 2 3 2 
98 99 99 100 100 99 99 99 100 2 2 3 3 3 2 2 2 2 2 2 
99 98 100 100 99 98 100 99 100 2 2 3 4 3 3 3 3 3 2 2 
99 100 99 100 99 99 99 100 99 2 2 3 3 3 3 2 2 2 2 2 
99 99 98 99 99 99 99 99 100 2 2 4 3 3 2 2 2 2 2 2 
100 99 99 99 99 98 99 99 100 2 2 3 4 3 2 2 2 2 2 2 
99 99 99 99 98 99 99 99 99 2 2 3 2 2 3 3 3 3 2 2 
99 100 100 99 99 98 98 99 100 2 2 2 3 3 3 2 2 2 2 2 
99 100 100 99 99 99 99 99 99 1 2 4 4 2 3 3 3 3 2 2 
98 99 100 99 99 99 99 98 100 2 2 3 2 3 2 2 2 2 2 2 
99 100 100 98 98 100 100 99 100 1 2 4 4 4 3 3 3 3 2 2 
99 99 99 98 99 99 99 99 99 1 2 3 3 3 2 2 2 2 3 3 
99 99 98 100 99 99 99 99 100 1 2 3 3 4 3 2 2 3 2 2 
99 100 99 99 99 99 100 100 100 2 3 4 3 3 2 2 2 2 2 2 
99 100 100 100 99 99 99 99 100 1 2 3 3 3 2 2 2 2 2 2 
99 99 98 100 99 98 100 99 100 2 2 3 4 3 3 3 3 3 2 2 
 
